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ABSTRACT
Mastitis, the inflammation of the mammary gland by bacterial infection, is one of
the costliest diseases to the dairy industry primarily due to a loss in milk production. The
aim of this study was to investigate the mechanisms underlying reduced milk production
during mastitis. We hypothesized that bacterial endotoxin induces cell apoptosis,
oxidative stress and increases hypoxia while inhibiting milk gene expression in the
mammary gland. To test this hypothesis, mice were bred to pregnancy, and 3 days postpartum the left and right sides of the 4th pair of mammary glands were alternately
injected with either the endotoxin liposaccharide (LPS, E. coli 055:B5, 100 ul of 0.2
mg/ml) or sterile PBS through the teat meatus. At 10.5 and 22.5 h post-injection,
pimonidazole HCl, a hypoxyprobe, was injected intraperitoneally. At 12 or 24 h after the
LPS injection, the fourth glands were individually collected (n=8 pairs) and analyzed for
hypoxia, gene expression and oxidative stress. LPS treatment induced mammary gland
inflammation as shown by increases in inflammatory cytokine expression (P < 0.001) and
neutrophil recruitment at 12 and 24 h. LPS promoted cell apoptosis in a transient manner;
an abundance of cleaved caspase 3 was evident only at 12 h after LPS challenge (P =
0.02). Increased H2O2 content was seen at 12 h (P < 0.001) but decreased dramatically
after 24 h of LPS treatment (P < 0.001). Total antioxidative capacity tended to decrease at
both 12 and 24 h (P = 0.067 and 0.061, respectively). In agreement with these findings,
LPS activated Nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidative signaling in
the mammary gland, demonstrated by increased expression of its target gene Nqo1 at 12
h (P = 0.05) and xCT at 24 h (P = 0.076). Hypoxyprobe staining, indicative of hypoxia,
was greater in the alveoli of PBS-treated glands than LPS-treated glands at both 12 and
24 h. This suggests oxygen tension rises in response to LPS treatment. Conversely, milk
expression genes, β-casein gene (CSN2) and α-lactalbumin (LALBA), were inhibited by
LPS treatment across time. Expression of α-S1 casein (CSN1S1) mRNA increased with
LPS treatment at 24 h, but protein expression was reduced at this same time point (P <
0.05). In summary, intramammary LPS challenge incurs inflammation, augments cell
apoptosis, induces oxidative stress and activation of the Nrf2 antioxidation pathway,
increases oxygen tension, and inhibits milk protein expression in the mammary gland.
This study provides functional insight into mechanisms of reduced milk production
during mastitis and provides possible approaches to combat reduction in milk production,
such as enhancing the Nrf2-antioxidative signaling pathway and reducing inhibition of
milk protein expression.
Keywords: Antioxidation, Gene expression, Hypoxia, Inflammation, Mastitis, Nrf2
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Chapter 1: Literature Review
1.1. Introduction
Mastitis, one of the costliest diseases in the dairy industry, is inflammation of the
mammary gland commonly caused by intramammary bacterial infection. Bacterial
invasion of the mammary gland through the streak canal allows such organisms to
proliferate on nutritious milk components, such as lactose and caseins (Zhao et al., 2008).
Macrophages and other innate immune cells produce inflammatory mediators that recruit
polymorphonuclear neutrophils (PMNs) and other immune cells towards the infected
areas. These cells cross tight junctions of mammary epithelial cells (MECs) from the
stromal tissues and enter the alveolar lumen, which stimulate the inflammatory hallmarks
of heat, pain, redness, and swelling in the mammary gland (Zhao et al., 2008). This,
however, is not seen in subclinical mastitis, which accounts for most mastitis cases
annually (Zhao et al., 2008), but milk production is also negatively affected in subclinical
mastitis. Mastitis also results in increased pH, sodium and chloride ion content, and
somatic cell count in milk that ultimately force farmers to discard this low-quality milk
(Ogola et al., 2007). The loss in milk production is the primary economic cost of mastitis
with increased veterinary care and other factors totaling annual losses at $2 billion
(Suszkiw, 2002). The specific mechanisms of how mastitis inhibits milk synthesis of the
mammary gland are not clear, thus, we aim to determine the potential reasons for the loss
in milk production by mastitis. In this review, our current knowledge in mammary
development, milk protein and lactose synthesis, the pathophysiology of mastitis, and the
role of oxidative stress and hypoxia in mastitis are introduced.
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1.2. Mammary Gland Development and Lactogenesis
The mammary gland is a dynamic organ that develops throughout the life of
mammals. This skin organ, upon maturity of the mammal, undergoes cyclical changes in
four stages: mammogenesis, lactogenesis, galactopoiesis, and involution. The actions of
MECs, stromal cells, and immune cells work in concert with reproductive hormones,
metabolic hormones, and locally produced factors to accomplish this feat. This section
discusses the stages of mammary development and the intricate processes that permit
these changes to proceed in a coordinated manner.
1.2.1. Mammogenesis
The parenchymal tissue of the mammary gland is developed by the process of
mammogenesis in all mammals. Long before the mammary gland produces milk, it
undergoes significant changes in 3 major phases: fetal, pubertal, and reproductive.
Fetal Development
During early development, the ectoderm of the embryo gives rise to all epithelial
tissue while the fat pad and all other stromal tissue stems from the mesoderm. In mice,
fetal mammary gland development commences with the mammary band, a line of
ectodermal cells that will become the parenchyma (Veltmaat et al., 2003). The principal
activity occurring in this phase is the invasion of the ectodermal cells into the
mesenchymal layer, which eventually forms a divot on the embryo. It starts at day 10 of
embryogenesis in mice and day 32 in cattle with the mammary line, the structure which
expresses increased Wnt signaling relative to other tissues (Veltmaat et al., 2003; Akers,
2002). The next step is the formation of the mammary gland, which is aided by fibroblast
precursors of the mesenchyme that secrete fibroblast growth factor (FGF). FGF10
-2-

promotes Wnt10b signaling, and FGF receptor knockout mice lack placode development
(Dzięgelewska et al., 2018; Mailleux et al., 2002). In mice, the assembly of 5 pairs of
mammary placodes occurs by embryonic day 11 (Cowin et al., 2010). The invasion by
the ectoderm into the mesoderm forms buds at day 14 in females (Richert et al., 2000). In
males, the testes secrete androgens on day 13 and inhibit the developmental process with
the precursor gland sloughing off by day 15 (Richert et al., 2000).
Following these phases is when the mesenchymal layer grows to extend a
mammary bud from the body to form the primary sprout, the progenitor to the gland
cistern in cattle or the lactiferous sinus in humans and mice. More ectodermal cells
expand into the fat pad forming solid clusters of epithelia surrounded by minute layer of
fibroblast cells. Once this primary sprout reaches the fat pad precursor made up of
preadipocytes, it divides congruently to ultimately yield 10-15 branches known as
secondary sprouts in mice (Elo et al., 2017). In mice, the primary sprout is formed on day
16 followed by the secondary sprouts on day 17 branching in the mammary gland
(Richert et al., 2000). In cattle, formation of the primary sprout occurs around day 80 of
embryogenesis (Akers, 2002). To create a lumen within the epithelium, the canalization
of the mammary gland is initiated at the primary sprout. Canalization then proceeds
towards the secondary sprouts to form the gland cistern and ducts, respectively, as well as
towards the external surface to form the teat. Parathyroid-related hormone is
endogenously secreted in this tissue to act as a critical mediator of the phase shift from
bud formation to branching (Wysolmerski et al., 1998). The embryonic development is
completed by day 18.5 in mice and will remain quiescent until puberty and the mammary
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gland grows isometrically, the same rate as the rest of the body, during this period
(Sakakura, 1987).
Puberty
The mammary gland is a unique organ that undergoes cyclical growth and
functional differentiation following puberty. The pubertal stage of mammogenesis is
initiated following the stimuli of hormones and other controls expressed at the onset of
puberty. Primarily, the secretion of follicle-stimulating hormone and luteinizing hormone
from the anterior pituitary in a cyclical manner stimulates the secretion of estrogen and
progesterone from the ovary. Estrogen acts synergistically with growth hormone and
prolactin from the anterior pituitary to stimulate ductal branching and elongation, which
drives the allometric growth of the mammary gland. Allometric growth refers to a tissue
that grows at a rate faster than the rest of the body. This contrasts with isometric growth.
Estrogen mediated ductal morphogenesis occurs through estrogen receptor alpha, which
is integrally controlled in part by forkhead box protein A1 (Liu et al., 2016).
Progesterone, meanwhile, causes ductal cell proliferation, leading to the enlargement and
development of ductal side branching (Atwood et al., 2000). These hormones together
increase mammary epithelial growth tremendously alongside somatotropin, whose effects
may be largely mediated by increased insulin-like growth factor 1 (IGF-1) among other
paracrine signals. IGF-1 promotes cell growth, differentiation, and prevents apoptosis. In
mice and other rodents, paracrine signals like increased IGF-1 causes terminal end buds
to disseminate throughout the mammary fat pad. The terminal end bud structure in the
mouse mammary gland contains a single layer of cap epithelial cells containing numerous
stratified body epithelial cells that become myoepithelial cells and luminal epithelial cells
-4-

respectively (Williams and Daniel, 1983). Terminal end bud formation is due in part to
FGF signaling because FGF20 knockout mice have delayed invasion by ducts during
puberty (Elo et al., 2017). In ruminants and human, there are no terminal end buds, but
rather terminal ductal lobular units (TDLU). These are considered the developmental
unit of the mammary gland and have a similar bilayered structure of basal cells and
luminal cells that become myoepithelial cells and epithelial cells, respectively
(Dzięgelewska et al., 2018). Progesterone stimulates secretion of transforming-growth
factor beta (TGFβ), which inhibits alveolar growth and prevents milk production (Kim et
al., 2005). While the epithelial component of mammary tissue is similar across mammals,
the stromal composition varies greatly from species to species. Mice possess mostly
white adipose tissue with little fibrous connective tissue. Conversely, human and bovine
mammary tissue possesses more fibronectin and other fibrous connective tissue
(Dzięgelewska et al., 2018). Either way, the stromal tissue plays a vital role in mammary
development.
Stromal tissue can promote mammary growth via the production of TGF-alpha,
epidermal growth factor (EGF), and FGF by fibroblasts around terminal end buds
following activation by estrogen and somatotropin (Unsworth et al., 2014). FGF2
signaling inhibitor Spry2-knockout mice have increased elongation and invasion into the
fat pad during puberty while overexpression of Spry2 represses ductal morphogenesis
(Dzięgelewska et al., 2018). Adipose is necessary for the formation of an advanced ductal
network in puberty as well as in adulthood because the adipose provides signals to the
growing epithelium. CC chemokine ligand 2 and pro-inflammatory ERK1/2 signaling
promote estrogen biosynthesis in the mammary adipose tissue via increased aromatase
-5-

expression (Martínez-Chacón et al., 2019). Adipose specific vitamin D receptor knockout
mice fed a high fat diet have enhanced ductal morphogenesis despite no difference in fat
pad mass (Matthews et al., 2016) As this ductal network expands, so does the mammary
vasculature in a proportional manner to provide vital nutrients to the growing branches
(Yu et al., 2017).
In addition to stromal tissue, the immune system assists in the elongation and
dissemination of the terminal end bud. Mast cells are one of the first immune cells to
arrive to the TEB or TDLU in mice and cattle, respectively, and promote the extension of
ducts into the mammary fat pad (Beaudry et al., 2015). Interleukin-5 (IL-5) deficiency
reduces morphogenesis and pup survival (Dzięgelewska et al., 2018). Macrophages,
meanwhile, are recruited to the mammary gland and aggregate around the TEB of mice
or TDLU of cattle to promote collagen and stromal remodeling to pave the way for
parenchymal growth (Beaudry et al., 2015). Following the pubertal stage, the mammary
gland will not grow further until it is stimulated by cues unique to pregnancy.
1.2.2. Lactogenesis
Lactogenesis is considered the preparatory stage of the pregnant mammal’s
mammary gland for lactation and can be divided into 2 phases: lactogenesis I and
lactogenesis II. Before lactogenesis occurs, the animal must first become pregnant, which
elevates progesterone secretion along with a multitude of other factors. From here,
lactogenesis I commences at around mid-gestation, which coincides with the start of
exponential MEC growth and differentiation, including expression of milk synthesis
genes. Luminal epithelial cells of the mammary gland are stimulated to proliferate and
rapidly divide and form alveoli. The mammary alveolus, the secretory unit of the
-6-

mammary gland, is a structure containing a single layer of MECs enveloped by
myoepithelial cells, capillaries, and other mesenchymal tissue. Adipocytes in the
mammary gland decline to give way to cell proliferation in the formation of ducts and
changes in stromal tissue such as angiogenesis and structural support for the developing
secretory structure. Being an energy intensive process, the adipocytes become smaller as
they provide additional energy for the increased metabolic activity (Gregor et al., 2013;
Hovey and Aimo, 2010). The hormonal regulation of this development is species
dependent.
Prolactin stimulates prolactin receptors, a type of tyrosine kinase of the Janus
kinase family and mediates the phosphorylation and subsequent dimerization of signal
transducer and activator of transcription 5a (STAT5a) with STAT5b (Buonfiglio et al.,
2015). The dimerized STATs move into the nuclear compartment and stimulate
expression of milk synthesis genes. STAT5 knockout mice have a decreased ability to
produce milk as evidenced by decreased pup growth (Buonfiglio et al., 2015).
Translation of milk synthesis gene mRNA is inhibited at this time, which may be a result
of progesterone mediated expression of TGFβ (Kim et al., 2005).
When the mammal undergoes parturition, the mammary gland shifts from
lactogenesis I to lactogenesis II as hormonal cues play a major role in this conversion.
The hormonal activation of this shift is regulated by inhibitory progesterone and
stimulatory prolactin. As progesterone sustains pregnancy, its secretion decreases at
parturition and, along with a surge in prolactin secretion, stimulates the activation of milk
synthesis. To assist in this production, the endoplasmic reticulum (ER) stress factors
ATF4 and CHOP are upregulated to help manage the increased amount of stress placed
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on the ER at this phase by protein synthesis (Yonekura et al., 2017). CHOP expression is
not increased in mouse mammary tissue, which may be a result of lower total milk
protein production relative to cattle (Yonekura et al., 2017). X-box binding protein 1 and
ATF4, transcription factors of the unfolded protein response, are increased at this stage,
which may result in increased cell differentiation via increased expression of
glucocorticoid, insulin, and prolactin receptors (Tsuchiya et al., 2017).
In the mammary gland and the animal, there are several other changes that occur
in the periparturient period. Upon completion of birth, the cardiac output directed towards
the uterus is shifted to the mammary gland to support immense colostrogenesis and milk
synthesis (Graćner et al., 2015). The cow enters a state of negative energy balance where
her feed intake cannot match her metabolic demands, thus increasing non-esterified fatty
acids (NEFA) and beta-hydroxybutyric acid concentrations in the bloodstream (Abdelli et
al., 2017). The drop in progesterone coincides with rising mammary macrophage
populations, activating NF-κβ signaling to increase tight junction permeability by
cytokine signaling (Need et al., 2014). While there is no increase at the systemic level of
thyroid hormone, the mammary gland expresses more thyroxine-5’-deiodinase to convert
thyroxine to the more potent triiodothyroxine, which increases the metabolic capacity of
mammary tissue at and through lactation (Campo Verde Arboccó et al., 2017). Since
thyroxine-5’-deiodinase is somatotropin inducible, thyroid hormone activity is dictated
by somatotropin, and hypothyroidism decreases STAT5 activation (Campo Verde
Arboccó et al., 2017). The mRNA content of MECs increases 4-fold from late gestation
to the start of lactation, and the energy and protein demand increases 5-fold during this
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time as a result (Kuhn et al., 1999; Schingoethe et al., 1988). At this time, lactogenesis is
achieved and the mammary gland becomes fully operational.
Galactopoiesis
Once lactation is initiated, it must be sustained by the process of galactopoiesis. The main
stimulus to sustain this phase is milk letdown, and this lactation persistence is
coordinated by endocrine and paracrine factors. In mice and most other mammals,
prolactin is the primary galactopoietic hormone while somatotropin is the one in
ruminants. Prolactin is released along with oxytocin in a neuroendocrine response as the
hypothalamus coordinates their release from the anterior and posterior pituitary gland,
respectively. Prolactin exerts its effect via binding with prolactin receptor and activating
JAK-STAT signaling to stimulate further milk synthesis. Oxytocin, on the other hand,
targets myoepithelial cells to contract causing milk ejection. In ruminants, somatotropin
causes synthesis of downstream effector IGF-1 in the liver and locally in the mammary
gland while acting in concert with oxytocin and prolactin (Akers, 2006). IGF-1 also
promotes milk production in mice (Su, 2004). The exact role of somatotropin has yet to
be elucidated, but its receptor expression is increased in lactating mammary glands
(Sinowatz et al., 2000).
1.2.3. Mammary Involution and Apoptosis
Involution is the process by which the mammary gland shifts from galactopoiesis
to a non-lactating state. In general, the process can be divided into a reversible first phase
involving soluble factors and upregulation of the unfolded protein response followed by
an irreversible second phase of protease-dependent structural changes to return the
mammary gland to its quiescent state. The first period of involution is known as
-9-

reversible involution because milk removal will reverse any effects or signaling at this
time. Without suckling or other milk removal methods, oxytocin and prolactin secretion
is inhibited, thus reducing STAT5 activation. The main stimulus to induce involution is
cessation of milk removal which inflicts the accumulation of feedback inhibitor of
lactation (FIL), which can lead to irreversible involution if milk letdown does not occur
frequently enough. The process of involution is species-dependent as it happens within
48 hours for mice, rats and other rodents, while it can be much longer for cattle. In cattle,
milk protein gene expression remains unaltered until 3 days after weaning while
expression of interleukin 1 beta converting enzyme, which cleaves pro-IL-1B to active
IL-1B, increases within hours (Lund et al., 1996). As milk accumulates in the mammary
gland so does IL-1B, TNF-alpha and other pro-inflammatory cytokines that promote cell
death. Death receptor mediated apoptosis occurs through the release of cytochrome-c via
inhibition of Bcl-2 by Janus Kinase to activate caspase 3. Cellular inhibitors of apoptosis
proteins 1 and 2 prevent hyperactivation of caspase 3 and delay the cell death
characteristic of involution (Carr et al., 2018). All these soluble factors can be alleviated
by milk removal, thus emphasizing the importance of milk removal in the mammary
gland.
Without milk removal, involution can become irreversible by entering the second
stage of involution. Irreversible involution is characterized by clearance of secretory
epithelial cells, extracellular matrix reconstruction, and repopulation by adipocytes. The
second phase of involution culminates in the rigorous restructuring of the mammary
gland through local cues communicating with the immune system and mesenchyme of
the mammary gland. In ruminants, lactose synthesis decreases to lower milk volume and
- 10 -

cause involution. Milk protein content, on the other hand, increases with an elevated
amount of lactoferrin, immunoglobulins while milk protein synthesis is reduced. Milk fat
vacuoles accumulate in MECs and milk component synthesis is impaired. While
reduction of milk biosynthesis is noteworthy in involution, there are 3 key events in
irreversible involution: TGFβ production, STAT3 activation, and remodeling of the gland
structure.
Irreversible involution coincides with the epithelial-mesenchymal transition and
allows epithelial cells to lose their polarity and infiltrate the basement membrane. A
secreted protein central to these processes is TGFβ, which is inhibited by lactogenic
hormones and thus, increases in involution. TGFβ-1 promotes the growth of
mesenchymal cells while reducing epithelial cell proliferation as evidenced by decreased
milk synthesis and survival of MECs while promoting extracellular matrix deposition
(Sudlow et al., 1994). In fact, TGFβ-1 induces Bax mediated apoptosis in the mouse
MEC cell line, HC11 (Kolek et al., 2001). In this form of cell death, activated Bax is
translocated to the mitochondria to cause cytochrome-c leakage and activates caspase-3
to trigger programmed-cell death in MECs. TGFβ-1 can also stimulate apoptosis by
activating Smad2/3 transcription factors to promote expression of IGF binding proteins,
which reduce free IGF concentrations. In bovine MEC cell line BME-UV1, IGF binding
proteins prevent pro-survival signaling by the PI3K/Akt pathway and promote Baxmediated apoptosis (Gajewska et al., 2004).
TGFβ-3 helps the process of involution by reducing tight junction and adherens
junction integrity through activation of gamma-secretase, which cleaves E-cadherin and
releases beta-catenin (Fornetti et al., 2015). Beta catenin then translocates to the nucleus
- 11 -

to stimulate MEC differentiation to a phagocytic cell (Fornetti et al., 2015). MEC
differentiation for efferocytotic behavior is essential in proper involution. Deficiency of
Mer tyrosine kinase, which inhibits pro-inflammatory signaling and promotes
endocytosis in all phagocytic cells, impairs early processes of involution (Sandahl et al.,
2010). TGFβ upregulates arachidonic acid synthesis, a precursor to inflammatory
eicosanoids that are key signals to immune cells in this remodeling (Zhang et al., 2017).
TGFβ-3 has an active role in involution as its expression stimulates phosphorylation of
STAT3 within 8 hours of weaning (Nguyen, et al., 2000).
In contrast to reduced STAT5 at this stage, pro-apoptotic STAT3 increases to
initiate the second, irreversible phase of involution (Uejyo et al., 2015). As cytokine
production increases during involution, the tumor necrosis factor family of cytokines and
other inflammatory mediators cause leukemia inhibitory factor synthesis and activation of
STAT3 by Janus kinase (Quaglino et al., 2007). STAT3, stimulated by TGFβ-3, causes
STAT3-dependent MEC expression of CD14, which is essential to phagocytic capability
(Hughes et al., 2012). STAT3 activation promotes the expression of inhibitory subunits of
PI3K to inhibit pro-survival signals by pAkt (Schuler et al., 2016). STAT3 also induces a
phenotypic shift in macrophages from M1 to M2 (Hughes et al., 2012). Dendritic cells
are the first immune cell to appear in large numbers, which coincides with signaling
similar to wound healing (Martinson et al., 2014). Immunomodulatory signaling seen in
wound healing is critical to alter the macrophage function to increase their ability to
reconstruct the connective tissue of the mammary gland.
STAT3 also mediates the production of CAAT/enhancer binding protein δ
(C/EBP δ) and cathepsins B and L while inhibiting expression of Spi2a, a cathepsin
- 12 -

inhibitor, to encourage lysosomal mediated programmed cell death (LM-PCD) in MECs
(Hughes et al., 2018). As apoptotic bodies and fat accumulate without milk removal,
STAT3 coordinates MEC uptake of apoptotic bodies and milk fat globules, and the
plasma membranes lose their fidelity to permit cathepsin release and mediates lysosomal
mediated-programmed cell death (LM-PCD) (Sargeant et al., 2014). Milk fat globule
EGF 8 catalyzes this process by tagging extracellular phosphatidylserine, a hallmark of
apoptosis, on cellular debris and milk fat globules (Hanayama et al., 2005).
The stromal tissue increases in contrast to the decreasing luminal space, but
structures do not atrophy in ruminants. In contrast, alveolar structures in rodents are
abolished via cell death pathways. The primary cell death mechanism in rodents is
apoptosis, which can be characterized as soon as 48 hours since last milking in addition
to increased CD68 expression (Warri, et al., 2018). Remodeling of this tissue is
encouraged by matrix metalloproteinases that digest the underlying connective tissue
from the epithelium. Increased expression of proteolytic enzymes, such as stromelysin-1
and gelatinase-A secreted by some fibroblasts, is seen by day 4 of involution (Lund, et
al., 1996). The proteolytic digestion of the basement membrane detaches MECs, resulting
in their programmed-cell death. While the epithelial component is removed, the
adipocytes, which are no longer supplying massive amounts of energy for anabolism,
repopulate the mammary gland 4.1-fold relative to lactation and increase their fatty acid
content, therefore, cells are increasing in size (Zwick et al., 2018).
At the completion of mammary involution, the gland is ready to begin the cycle
once again. Through these cyclical developmental stages, the mammary gland can gain
more and more parenchymal tissue at the end of each cycle so that the next cycle will be
- 13 -

more productive. This intricate biology is widely studied, but many aspects of mammary
development remain elusive, such as the regulation of milk protein synthesis and the
effect of mastitis among other factors.
1.3.

Milk Synthesis
The ultimate purpose of the mammary gland is to synthesize and secrete milk for

the nourishment of the offspring. Milk is mainly comprised of proteins, carbohydrates,
fats and water to provide the young with all essential nutrients for growth and health.
While milk is a definitive characteristic of mammals, the composition varies greatly to
best support the neonates in their indigenous habitat. Bovine milk contains 3.2% protein,
4.8% lactose, and 3.5% fat on average while human milk is 1.1%, 6.8% and 4.5%, and rat
milk is 11.3%, 2.9% and 14.8%, respectively (Vincent et al., 2016; Jensen, 1995).
Despite differences across species, the synthesis of milk is relatively conserved. This
section will focus on the characteristics and synthesis of milk proteins in addition to the
production of lactose.
1.3.1. Milk protein synthesis
Milk Proteins
Milk proteins can be organized into casein proteins and whey proteins. Caseins
comprise 80% of milk protein and include 4 major proteins: beta-casein (gene symbol:
CSN2), alpha-S1 casein (CSN1S1), alpha-S2 casein (CSN1S2) and kappa-casein (CSN3)
(Vincent, et al., 2016). These proteins are expressed in the bovine mammary gland at
38%, 35%, 10%, and 12%, respectively (Vincent et al., 2016). Caseins are ~20 kD
phosphoproteins that attract calcium ions and condense to form micelles, which in turn
provide micronutrients with highly digestible proteins to the neonate. The whey fraction,
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18% of protein in bovine milk, is a heterogenous group and mainly includes alphalactalbumin (LALBA), serum albumin and immunoglobulins.
Milk proteins do not function solely for nutrition of the neonate. CSN2 has a high
biological value and can exist in 13 variants and possess 4 to 5 phosphorylated residues
(Vincent et al., 2016). CSN2 digestion produces biologically active peptides that have
negative and positive effects on the body. A1 CSN2 variant, but not A2 CSN2 variant,
increases the rate of type I diabetes in rats, and human type I diabetics have increased
ratios of A1/A2 antibodies relative to controls (Elliot et al., 1997; Padberg et al., 1999).
In a milk intolerance clinical study, it was found that those who consumed a non-dairy
milk control containing A1 CSN2 reported more occurrences of severe digestive
discomfort than those who consumed the A2 CSN2 analog (Ho et al., 2014). A2 CSN2
variants isolated from gouda cheese, on the other hand, have antihypertensive properties
(Saito et al., 2003).
CSN1S1 also has antihypertensive properties (Saito et al., 2003). CSN1S1 is one
of the major phosphoproteins found in milk that promote formation of colloidal micelles
with calcium phosphate. CSN1S1 has 9 variants with 8 to 9 phosphorylated residues
(Vincent et al., 2016). CSN1S1 is an activator of TLR4 signaling and subsequent proinflammatory cytokine signaling in human monocytes (Vordenbäumen et al., 2016).
These results were later confirmed as human recombinant CSN1S1 induced TLR4/MD2
receptor complex mediated IL-8 secretion from HEK293 cells (Saenger et al., 2019).
Transcriptional Regulation
In protein synthesis, a gene must be first transcribed from DNA to RNA. Milk
protein gene transcription is cis-regulated through transcription factor mediated effects of
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multiple hormones, such as insulin, prolactin, and glucocorticoids (lactogenic hormone
complex, HIP). Being a conserved process across most casein proteins, the CSN2 gene is
widely utilized as a model for studying milk protein gene expression (Jones et al., 1985).
Approximately 250 bp upstream from the CSN2 gene transcription start site (TSS) is its
proximal promoter that is preceded by the distal enhancers -1.6 to -6 kb upstream of the
TSS depending on species (Qian et al., 2014). The transcription factors that target the
promoter include STAT5, C/EBPβ, and the repressor Yin Yang 1 (YY-1) along with the
glucocorticoid receptor, octamer binding factor-1 (Oct-1), and runt-related transcription
factor 2 (Runx2) (Qian et al., 2014). The distal enhancer of the CSN2 gene exerts its
action in combination with binding with these transcription factors too (Qian et al.,
2014).
STAT5 is activated by prolactin via phosphorylation by Janus kinase (JAK). The
action of STAT5 is amplified by glucocorticoid receptor, which increases efficiency of
STAT5 phosphorylation and DNA binding (Pfitzner et al., 1998). STAT5a is a critical
transcription factor of milk synthesis; STAT5a knockdown mice have decreased milk
protein synthesis and reduced gap junction integrity (Reichstein et al., 2011). YY-1 is a
weak repressor of milk protein expression that is easily dislodged by STAT5 and C/EBPβ
binding at the CSN2 promoter (Wyszomierski et al., 2001).
While prolactin and glucocorticoids work together to stimulate milk protein
synthesis, insulin also plays a key role. It may work through PI3K/Akt signaling pathway
as this stimulates expression of the enhancer E74-like factor 5 (ELF5) that binds to the
CSN2 proximal promoter (Lemay et al., 2007). While Oct-1 can act with progesterone
receptor to inhibit CSN2 expression during pregnancy, Runx2 can bind with Oct-1 to
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enhance transcription of CSN2 (Inman et al., 2005; Qian et al., 2013). In a coordinated
manner, these transcription factors synergize to stimulate milk protein mRNA synthesis.
Following transcription, the mRNA is utilized as a blueprint to build proteins.
Translational Regulation
After transcription, the primary transcript (pre-mRNA) moves from the nucleus of
the cells to the rough ER to be translated by ribosomes. Before translation, the premRNA undergoes modifications, such as the removal of introns to leave the 9 exons
(mature mRNA) of the CSN2 gene (Jones et al., 1985). Translation of milk protein
mRNA is an involved process that depends on amino acid availability, accessible energy
content, and signaling of the principal translational regulator, the mTOR pathway.
Together, these processes work in concert to translate milk protein mRNA in a carefully
ordered manner.
In order to produce milk protein from mRNA via translation, amino acids must be
supplied to the MECs. This is done with amino acid transporters, which transfer all
essential amino acids and partial non-essential amino acids from the extracellular fluid
into the cells. Amino acid transporters found in MECs include sodium dependent and
sodium independent transporters and both differ in function and specificity of amino
acids transported. Sodium-dependent transporters deliver glutamate, taurine and anionic
amino acids in conjunction with sodium transport whereas sodium-independent transport
targets neutral and cationic amino acids (Shennan et al., 1997). The rest of non-essential
amino acids can be synthesized by the cell. Amino acid supplementation is positively
correlated with bovine milk protein content (Lin et al., 2018).
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The availability of energy is essential for protein synthesis like any other anabolic
process. In the case of protein synthesis, the need for energy is great as the animal shifts
into negative energy balance at parturition and sustains this state in early lactation (Gross
et al., 2011). In fact, cows on energy restricted diets have decreased milk yield with
lower protein content in as little as one week (Gross et al., 2011). What is interesting is
that increased starch ingestion raises milk protein synthesis more than supplemental
protein by increasing mammary blood flow and reducing amino acid catabolism (Rius et
al., 2010). By transcriptome analysis, it was found that overall mammary gland gene
expression of metabolic components is increased in lactation, including amino acid
transaminases to supplement the Krebs cycle while glucose is directed to lactose
synthesis rather than energy production (Bionaz et al., 2012). Energy status of the MECs
controls mTOR signaling through activation of AMPK. Low cellular ATP concentration
leads to increased AMPK phosphorylation to reduce mTOR activation and increase
eukaryotic elongation factor-2 kinase (eEF2K) phosphorylation to inhibit translation
(Appuhamy et al., 2014).
The mTOR pathway is the main pathway that regulates the translation of milk
protein genes in accordance with nutrient availability and cues in the mammary gland. It
serves to phosphorylate eukaryotic translation initiation factor 4E (eIF4E) binding protein
1 to activate eIF4E mediated translation initiation complex formation (Ma et al., 2009). It
also deactivates eEF2K to activate its target and promotes ribosomal protein S6 to
increase overall translational efficiency (Ma et al., 2009). To prevent inappropriate
mTOR activation, amino acid sensing is tightly coordinated with these translational
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machineries. Amino acid sensors like arginine sensor SLC38A9 activate Rag-GTPase
regulator complex, which is responsible for mTOR activation (Wyant et al., 2017).
Nutrient availability, however, is not the only factor in the PI3K/Akt/mTOR
pathway. The lactogenic hormone complex of HIP upregulates mTOR signaling greater
than supplementary amino acids, glucose and acetate in bovine-derived mammary acini
via Akt activation (Burgos et al., 2010). Both insulin and prolactin mediated signaling
reduces activated menin, which is a negative upstream regulator of mTOR activity via
inhibition of PI3K activation of Akt (Li et al., 2017). Insulin promotes translation of
CSN2 mRNA by recruiting cytoplasmic polyadenylation element binding proteins to
lengthen the poly-A tail and drives forward the initiation of translation (Choi et al.,
2004). Prolactin activates JNK mediated tudor staphylococcal nuclease translocation to
the nucleus, which stimulates mTOR signaling and CSN2 synthesis (Zhang et al., 2019).
Bovine and swine mammary tissue presented evidence for somatotropin as an
activator of the mTOR pathway and subsequent mRNA translation, initiation and
elongation (Hayashi et al., 2007; Burgos et al., 2010). Somatotropin increases 4E-BP1,
eEF2K, and ribosomal protein S6 phosphorylation to enhance initiation and elongation of
translation (Hayashi et al., 2009). The effects of somatotropin are potentially mediated by
IGF-1, which activates mTORC1 kinase activity (Burgos et al., 2010). Annexin A2, a
calcium dependent phospholipid binding protein, upregulates milk synthesis and MEC
proliferation by increasing PI3K-Akt mediated mTOR activation and cyclin D1
expression (Zhang et al., 2018).
Following translation, caseins proteins must be modified by specific kinases to
become phosphoproteins. Caseins are transported from the rough ER to the Golgi
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apparatus to receive post-translational modifications. The main sites of casein
phosphorylation are serine and threonine residues with CSN2 being phosphorylated on 4
to 5 residues and CSN1S1 on 8 to 9 residues (Farrell et al., 2004). The CSN1S1 8
phosphorylation residue isoform is expressed 3-fold greater than the 9-residue isoform
and, while it is known that Golgi-enriched fraction casein kinase phosphorylates the 8residue isoform and most other caseins, the kinase responsible for the 9th
phosphorylation is unknown (Bijl et al., 2014). While many things are known about milk
protein synthesis, the mysteries surrounding it remain abundant.
1.3.2. Lactose Synthesis
Glucose Uptake
Simple sugars, such as glucose, provide energy to cells for metabolic and
biosynthetic purposes. In the MECs, glucose is also the major precursor for lactose
synthesis (Zhao, 2014). MECs express multiple facilitative glucose transporters (GLUTs)
that facilitate the uptake of glucose and other monosaccharides in a closely monitored
manner (Zhao and Keating, 2012). Glucose uptake is driven by hexokinase
phosphorylation to maintain a concentration gradient. In MECs, most of the glucose
transporters face the basolateral membrane as glucose comes from the bloodstream, thus
flowing down its concentration gradient (Brun del Re et al., 2010). GLUT1 is the primary
transporter found here and plays a major role in glucose uptake in MECs (Zhao et al.,
2007). The concentration of glucose within the cell is approximately the same as that of
the milk (Kuhn et al., 1975). To generate lactose, glucose must be transported into the
Golgi apparatus via these transporters. Prolactin causes GLUT1 subcellular localization
to the Golgi apparatus membrane to facilitate glucose transport into the Golgi apparatus
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for glycosylation and lactose synthesis (Riskin et al., 2015). In addition to GLUTs,
MECs express sodium dependent glucose cotransporters (SGLT1 and SGLT2) (Zhao,
2014), but their physiological function is not known. In bovine mammary glands, there is
a sharp rise in GLUT1 expression with less dramatic increases in GLUT8, GLUT12 and
SGLT1 to coincide with increased glucose uptake from late gestation to early lactation
(Zhao et al., 2007). While this trend is observed in different species, it remains unclear
whether lactogenic hormone complex HIP or somatotropin mediates these increases or
some other factors (Shao et al., 2013, Zhao et al., 1996). What is known, however, is that
GLUT4 expression is decreased in the mammary gland during this period, which
coincides with a decrease in adipose tissue and a decrease in insulin sensitivity during
lactation (Zhao et al., 1996).
While galactose can be transported by GLUT for its uptake, the MECs can
synthesize their own. By generating glucose 6 phosphate, MECs can synthesize galactose
by a series of enzymatic reactions. Uridine diphosphate-glucose is generated from
glucose and uridine triphosphate and then, via UDP-Galactose-4 epimerase, UDP-glucose
is reconfigured into UDP-galactose (Sprong et al., 2003). UDP-galactose is transferred to
the Golgi apparatus where it is combined with free glucose to form lactose (Neville et al.,
2018).
Beta-Galactosyltransferase
Lactose synthase is the enzyme responsible for the condensation reaction that forms
lactose. Lactose synthase is a heterodimeric enzyme, consisting of beta 1-4
galactosyltransferase-1 (b4GALT1) and regulatory subunit LALBA. b4GALT1 is a
constitutively expressed enzyme in most cells found along the interior of the Golgi
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apparatus (Smith et al., 1977). The isoform found in the Golgi apparatus of MECs is
responsible for catalyzing the formation of D-galactosyl-N-Acetyl-D-Glucosamine in a
non-lactation state, which is its normal function across tissues (Smith et al., 1977).
b4GALT1 utilizes UDP-galactose to condense with N-Acetyl-D-glucosamine (Glc-NAc)
in formation of galactosylated glycoproteins (Smith et al., 1977). About halfway through
pregnancy, the start of lactogenesis I, this enzyme’s substrate switches to lactose
formation by acquiring an affinity for D-glucose rather than Glc-NAc (Smith et al.,
1977). The expression of b4GALT1 is increased 2.5-fold from mid-gestation to early
lactation in sows (Chen et al., 2017).
Alpha-Lactalbumin
b4GALT1 forms a heterodimer with LALBA to form fully functional lactose
synthase. LALBA comprises 25% of the total protein content in human milk and a
quarter of the bovine whey fraction, which amounts to 3% of the bovine milk protein
(Holm et al., 2018). The expression of LALBA starts at lactogenesis I and continues until
the end of lactation, and LALBA increases the binding affinity of b4GALT1 for glucose
1000-fold relative to b4GALT1 alone (Nicoleta et al., 2010). Being a carbohydrate,
lactose cannot diffuse out of the Golgi apparatus and is instead secreted into the alveolar
lumen with milk proteins. Because of this, water is recruited to the Golgi and secretory
vesicles and, therefore, the Golgi and secretory vesicles are round and expanded in
lactating MECs. While lactose synthesis is the primary biological function of LALBA,
this protein can fulfill other duties. It also binds calcium, cobalt, and zinc ions in the
whey fraction of milk (Nicoleta et al., 2010), and prevents coagulation of bovine milk
proteins in a synergistic manner with CSN2 (Marciniak et al., 2018).
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Lactose and protein synthesis contribute a major amount of nutrition derived from
milk. The milk composition of mammals is species dependent, but the principal
machinery in milk synthesis remains relatively similar. The end-product of this synthesis,
milk, is a desirable food source for neonates and mankind.
1.4. Mastitis
The high nutrient content of milk makes it desirable to not only mammals, but
bacteria as well. The lactating mammary gland is often the site of bacterial invasion and
infections that result in mastitis. Bacterial infection is almost the sole cause of mastitis in
cows, but the types of mastitis are varied based on the source and species of these
etiological agents and the virulence factors presented by these bacteria.
Inflammation is defined by the four characteristics of heat, pain, redness and
swelling, and the mammary gland is no exception to this. Mastitis causes not only
physiological changes, but it can also create physical changes in the gland’s appearance
and function. The invading pathogens activate the innate immune system, which is
responsible for these changes such as a rise in temperature to promote immune function.
The inflammatory signaling by the innate immune system causes nerve cells to sensitize
and blood vessels to dilate, thus causing the skin to become more tender and red. This
vasodilation is accompanied by breaches in the tight junction of MECs to create a route
for immune cell migration. As a result, milk quality suffers as milk production decreases
and sodium, serum and immune components from the extracellular fluid flood the
mammary lumen to displace the protein production. This milk also contains very little
lactose and high amounts of somatic cells as the infection progresses. The ultimate result
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of the immune action in mastitis is a vastly decreased milk yield with low quality product
that is unfit for human consumption.
1.4.1. Types of Mastitis
While mastitis results in poor milk production and quality, the severity of
infection varies greatly from case to case. Mastitis that causes clinical symptoms is
known as clinical mastitis whereas mastitis presenting few if any symptoms is considered
subclinical. Clinical mastitis is the most severe of these 2 types and is more lethal as its
acute infections present severe local inflammation with sepsis-induced fever and other
systemic effects. Endotoxemia is often a critical condition developed in prolonged
clinical mastitis (Peters et al., 2015). Unlike clinical mastitis, subclinical mastitis is often
asymptomatic and goes unnoticed, resulting in more chronic infections (Peters et al.,
2015). Mastitis can be evaluated based on the milk yield, electrolyte content and somatic
cell count. Severity of mastitis increases with somatic cell count and electrolyte
concentration while milk yield presents an inverse relationship and is more and more
repressed as the condition worsens (Bagri et al., 2018).
Mastitis can also be divided into 2 subclasses based on the source of infection:
environmental mastitis and contagious mastitis. These two types of mastitis have key
differences in the mode of transmission and the bacterial species behind mammary
infections. Environmental mastitis occurs more often during the summer when heat
stimulates bacterial growth in water, feces, bedding, mud and other areas the cattle may
meet. Flies can carry coliforms from fecal matter and hardy Gram-Positive bacteria. The
etiological agents behind this type of mastitis can potentially include Escherichia coli (E.
coli), Streptococci, and Pseudomonas spp.
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Contagious mastitis is spread from cow to cow through contact with contaminated
skin or sponges and towels used to wash the udder, or from calf to cow via suckling.
Milking can cause milk fomites to disperse into the environment or to contaminate the
milking equipment. Etiological agents for contagious mastitis include Gram-Positive
cocci Staphylococcus aureus (S. aureus) and Streptococcus agalactiae (S. agalactiae)
along with Mycoplasma bovis (M. bovis). These are often commensal organisms on
human skin and cannot thrive in an environment separate from the host. These infections
commonly result in subclinical and chronic infections, especially S. aureus.
1.4.2. Bacterial Pathogens
As stated earlier, mastitis is often the result of bacterial infection. Because
mastitis is caused by mostly S. aureus, streptococci, M. bovis and Gram-Negative
bacteria, the infections that stimulate inflammatory responses are coordinated in part by
the nature of the pathogen and their surrounding environment (Cote-Gravel and Malouin,
2019). In this section, the pathogens most commonly associated with mastitis, listed
above, will be discussed with their virulence factors and how they impact this infectious
disease.
Staphylococcus aureus: In the dairy industry, S. aureus is considered one of the
most commonly found etiological agents of mastitis and is of significant interest in
medicine. S. aureus is a Gram-Positive coccus that displays clustering formation in Gram
stains and are non-motile. They have many defining qualities among other
Staphylococcal species, such as catalase positive and coagulase positive test results. They
are desiccant resistant and halotolerant, which is a reason why they can successfully
colonize the skin of humans and other mammals. S. aureus infection can be divided into
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3 steps: adhesion to the ECM of the host, dissemination throughout the tissue and
immune evasion (Middleton, 2008; Cote-Gravel and Malouin, 2019). S. aureus has many
adhesins and binding proteins to assist it in anchoring itself and hiding from the immune
system. The expression of adhesins in S. aureus is dictated by Sigma Factor B to increase
adherence factors: collagen adhesin, fibronectin binding proteins A and B, teichoic acid
of the cell wall, and microbial surface components recognizing adhesive matrix
molecules (MSCRAMMs) (Horsburgh et al., 2002; Otto, 2013).
As the cocci divide and replicate, the action of polysaccharide intercellular
adhesin (PIA) allows S. aureus to bind to fellow microbes for biofilm formation and
allow for evasion from neutrophil offenses (Sendi et al., 2009). When the growth rate is
reduced towards stationary growth, the production of secreted exotoxins and other
proteins is upregulated as autoinducing peptides (AIPs) activate sensor kinase AgrC to
activate AgrA (Novick et al., 2008). AgrA upregulates small RNAs to promote exotoxin,
protease and lipase synthesis and repress surface protein expression while AgrD codes for
pro-AIPs (Novick et al., 2008). The breakdown of connective tissue by hyaluronidase
allows S. aureus to infiltrate the stromal tissue of the mammary gland and potentially
invade the capillaries and vessels.
To evade the immune system directly, S. aureus expresses numerous surface
factors outside of PIA. Iron surface determinant A not only helps in sequestering iron
from heme, but also binds fibrinogen and other serum proteins to the cell wall and form a
protective clot (Clarke et al., 2009). These bacteria can release themselves from the clot
by the action of Staphylokinase, an endogenous fibrinolysin, and this virulence factor can
impair α-defensin and other soluble defense proteins (Jin et al., 2004). S. aureus is also
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resistant to opsonization by immunoglobulins by the action of Staphylococcal protein A
(SpA), which binds the conserved region of IgG antibodies that are prevalent in milk,
along with staphylococcal binder of immunoglobulin (Serruto et al., 2010; Cole et al.,
2016). S. aureus extracellular adherence protein binds ICAM-1 on endothelial cells along
with fibrinogen to inhibit PMN adherence to endothelium and diapedesis. They can also
avoid being captured by PMN NETosis with DNAses and can also inhibit phagosomelysosome fusion in a SpA-mediated manner in vitro (McGuinness et al., 2016; Menegazzi
et al., 2012).
S. aureus targets immune cells with a bevy of other toxins. From isolates of cattle
with mastitis, S. aureus species secrete gamma hemolysins HlgAB and HlgCD,
leukocidins (Luk) lukAB, lukED, and LukMF, and Panton-Valentine leukocidin (Vrieling
et al., 2016). These pore-forming toxins specifically target cells expressing certain
differentiation markers, like how LukED binds to CD195 (Alonzo et al., 2012). LukMF,
but not LukAD, is the most potent leukocidin in bovine mastitis isolates (Vrieling et al.,
2016).
While S. aureus possesses a plethora of virulence factors and other adaptations, it
often lacks the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and
CRISPR associated system to protect against foreign genetic material. Because of this, S.
aureus is very susceptible horizontal gene transfer, which is influenced by mobile genetic
elements and can get genes to stimulate differentiation (Li and Zhao, 2018). In mastitis,
MRSA ST398, a livestock associated strain, has been isolated more frequently in recent
years and possesses SCCmec IV and V (Vanderhaeghen et al., 2010). This means that the
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efficacy of the most commonly used antibiotics, beta-lactams, is reduced as this
infectious disease adapts.
Streptococcus agalactiae: S. agalactiae are gram-positive diplococci of the group
B streptococci and are non-motile, mesophilic, facultative anaerobes. This species is betahemolytic, which is essential for their function as they are auxotrophic for heme as well
as for the L-isomer of many amino acids: arginine, cysteine, glutamic acid, histidine,
isoleucine, leucine, lysine, methionine, phenylalanine, proline, tryptophan, tyrosine and
valine (Glaser et al., 2002). This bacterium’s reservoir is both in the host and in the
environment. This species is often implicated in subclinical infections, and infected
udders are a major reservoir. The disease can be transmitted by cow to cow transmission
in udder washing and milking procedures. This species often infects during early
lactation because of the immunosuppression by stress, low energy by low dry matter
intake, and exposure to a milking machine that may be contaminated. S. agalactiae is a
metabolically crippled bacterium implicated in numerous contagious and environmental
mastitis cases.
Streptococcus uberis: S. uberis is another streptococci associated with more
subclinical bovine mastitis cases, but does not have a streptococcal Lancefield grouping.
It is an environmental pathogen found in manure or contaminated bedding and soil. It is
also a commensal microbe and found along the body, the epidermis, genital tract, and
tonsils of mammals, thus its prevalence fits its name. Although it is seemingly ubiquitous,
S. uberis is auxotrophic for a variety of amino acids: glutamic acid, arginine, tryptophan,
methionine, isoleucine, leucine, valine and histidine (Kitt et al., 1997). S. uberis
commonly infects mammary gland during early involution, and these infections can often
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continue into early lactation if not resolved. This species is considered a causative agent
of subclinical mastitis more so than clinical mastitis.
Mycoplasma bovis: While not an issue in the United States, M. bovis causes
contagious mastitis. M. bovis is not identifiable by gram staining due to a lack of
peptidoglycan cell wall components found in either gram-negative or gram-positive
bacteria. As a result of this, it is resistant to the antibiotics such as beta-lactams,
bacitracin, and vancomycin. This bacterium is metabolically crippled and cannot produce
its own ATP due to missing pieces of the oxidative phosphorylation pathway and lacks
the capacity to operate the TCA cycle (Burki et al., 2017). To overcome these issues, it
expresses numerous adhesins to bind to and invade the host cells for survival (Burki et
al., 2017). They sometimes can create clinical mastitis but can also cause subclinical
infections that make identification difficult. This is the most severe of all infections
discussed because there is no cure for this infection and can disseminate quickly
throughout a herd. The only certain way to contain the infection is to identify infected
cows, separate them from the herd, which will usually lead to culling due to complete
loss of production.
Escherichia coli and Klebsiella pneumoniae Gram-Negative rods: These bacteria
are members of the Enterobacteriaceae family and are commonly found along the lower
gastrointestinal tract of animals. These bacteria are implicated in more cases of
environmental mastitis as their environmental reservoirs are manure and contaminated
bedding. They are transmitted into the mammary gland by teat contact with contaminated
materials or from milking procedures with suboptimal cleaning procedures. This type of
infection is more likely to occur during the summer as the high temperatures provide
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more favorable conditions for microbial growth, and heat stress is inflicted upon the cow
that may stimulate immunosuppression by the hypothalamus-pituitary-adrenal axis. This
is critical as one of their major endotoxins, lipopolysaccharide (LPS), initiates severe proinflammatory responses in a TLR4/MD2/CD14 coreceptor mediated manner that can
result in febrile response, hypotension, and even death in cattle (Silanikove et al., 2011;
Saenger et al., 2019).
1.4.3. Pathophysiology
Being a dynamic organ undergoing cyclical changes, the mammary gland is prone
to diseases at certain points in the developmental cycle. Particularly, the periparturient
period, early lactation, and involution are phases that leave the mammary gland at risk of
infection. During the period shortly before and during calving, colostrogenesis takes
place with IgG1 being the predominant antibody in addition to anti-LPS and other
antibodies specific to bacterial toxins (Vilte et al., 2008). The colostrum also has little
lactoferrin yet high citrate, which means there are fewer immune components to
neutralize bacteria. Cows also begin to leak colostrum and milk components from teat
ends during parturition due to pressure build up within the gland. This weakens the teat
meatus and sphincter muscles and increases the likelihood of pathogen invasion.
Another time of increased risk of mastitis for dairy cows is early lactation. The
cow enters early lactation where milk yield progressively increases and cows have a
negative energy balance (Gross et al., 2011). An energy deficit results from decreased dry
matter intake, a behavior that starts during the peripartum period. Body fat deposits are
mobilized to meet the energy deficit (Abdelli et al., 2017), raising circulating betahydroxybutyrate and NEFA concentration. The rising of ketone bodies and NEFA in the
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blood is immunosuppressive, causing decreased PMN NETosis and decreased
phagocytosis in cattle (Ingvartsen and Moyes, 2015). In addition, immune activity is
limited by low glucose availability, the primary energy source of the immune system
(Ingvartsen and Moyes, 2015). The endocrine changes and nutrient shift may also
contribute to the low energy state of the mammary gland during the peripartum period.
Immune cells of the mammary gland are affected by endocrine signals and
paracrine signals. Increased estrogen promotes immunosuppression of regulatory T cell
populations (Habib et al., 2018). Progesterone and prolactin, meanwhile, raise regulatory
T cell populations indirectly during pregnancy and lactation, respectively (Leehy et al.,
2018). Involution is another time of great mastitis incidence. This is especially true of
active involution as the mammary gland continues to secrete milk that increases
intramammary pressure on the teat meatus and sphincter muscles. The remodeling of the
mammary gland during involution also occupies the resident immune cells with dead cell
or milk debris in the alveolar lumen. Ultimately these factors result in decreased immune
cell response to infection in the involuting mammary gland.
The immune status of the mammary gland is due in part to mucosal immunity.
The apical membrane of the lactating mammary epithelium secretes an ECM and a
mucus border that provides immune components such as IgA from CCL28-recruited Bcells and pore forming mucins (Wilson et al., 2004). The mucosal lining also acts as a
barrier in addition to the ECM against the immune components and free radicals found in
the milk (Ballard et al., 2013). The mucosal lining is also where antigen presenting
dendritic cells reside. These cells are of interest because their ability to activate T-cells is
suppressed in lactation and early involution but is most active by mid-involution (Betts et
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al., 2018). This contributes as a factor of increased mastitis susceptibility at early
lactation and early involution.
The pathogen invades the mammary gland through the streak canal and
Furstenberg’s rosette, thus entering the teat and gland cisterns. To get here, the pathogen
must get by the keratin plug, which immobilizes many bacteria, and the sphincter
muscles that keep the teat end closed. From here, bacteria invade the mammary gland,
proliferate, and produce toxins and metabolites which activate several signaling
pathways. LPS binds to the CD14/MD2/TLR4 co-receptor that stimulates cytokine
release and reactive oxygen species (ROS) production from MECs, PMNs, macrophages
and other immune cells, and activates soluble immune factors (He et al., 2015).
Initially, the bacteria are targeted by soluble immune factors, such as betadefensin, LPS-binding protein, lysozyme, lactoferrin, immunoglobulins and the
complement system. These are synthesized by MECs into the milk with beta defensin and
lysozyme forming pores in bacterial membranes to induce lysis and lactoferrin
sequestering iron, a vital and volatile nutrient, from bacteria to inhibit their growth
(Günther et al., 2009). MECs also secrete xanthine oxidase on milk fat globule
membranes and lactoperoxidase which destroys bacteria in the presence of thiocyanate
and hydrogen peroxide. IL-1B, TNF-alpha, and IL-6 are among the cytokines that initiate
this response, and it has been shown that wound response genes such as vascular
endothelial growth factor (VEGF) are induced to support angiogenesis (Younis et al.,
2016). Immune components such as the complement system, immunoglobulins, defensins
and lysozymes are all upregulated at this initial stage while ECM genes are suppressed at
this time (Younis et al., 2016). This is likely from increased extravasation and diapedesis
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of PMNs from the bloodstream and into the mammary gland coinciding with a rise in
milk sodium content and the loss of tight junction integrity. In fact, many of the
mammary gland immune components diffuse from the serum, such as transferrin.
Immunoglobulins (Ig), predominately IgG1 in bovine milk, opsonize pathogens and their
products to render them inert and mark them for destruction by macrophages early on.
In severe cases of mastitis, the persistence of infection in the mammary gland
stimulates the adaptive immune system as the cytokine signaling of the innate immune
system reaches the supramammary lymph node, the crossroads of the innate and adaptive
immune systems of the mammary gland. T-cell proliferation is stimulated, and B-cells
differentiate into plasma cells that actively produce antibodies or become memory cells to
prevent future infection. The increased permeability of the mammary epithelium and
vascular endothelium allows for secreted toxins to enter the bloodstream and exert
systemic effects. The action of TNF-α, IL-2, IL-6, and IL-8 stimulates the production of
eicosanoids, leukotrienes and prostaglandins. The former aid in the recruitment of more
PMNs and increase vascular permeability, while the latter promotes vasodilation and a
systemic febrile response in the host.
Mastitis in E. coli infected cows decreases the relative expression of α-S1-casein
1.8-fold and β-casein 2.5-fold, and E. coli LPS challenge results in a 75% reduction in
milk yield within 24 hours (McFadden et al., 1987). Intramammary challenge of cattle
with E. coli LPS drastically changes the metabolism from a predominately oxidative one
via mitochondrial processes to a primarily glycolytic metabolism in the cytosol
(Silanikove et al., 2011). This change in metabolism lowers the energy state of the cell,
thus the production of proteins and lactose decrease. This shifts the nutrients to help the
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immune system and produce antibacterial metabolites lactate and malate in the milk by
MECs (Silanikove et al., 2011). In accordance with this, Burgos et al. (2013) found that
AMPK, which is activated by low energy signals, inhibits mTORC1 through TSC1-2 and
decreased phosphorylation of 4E-BP1 and SK61.
1.4.4. Economic Impact to Dairy Industry
The dairy industry loses a great amount money to mastitis. Economic tolls
attributed to mastitis are mostly associated with reduced milk production. Holland et al.
(2015) devised a direct comparison interaction model and determined that milk yield
losses due to mastitis were 0.0388 kg/day per 1% rise in somatic cell count. This model
allows economic deficits to be related to mastitis severity by normalizing the cost in
losses to the number of cells shed in the milk. In the United States alone, mastitis
accounts for $2 billion in losses. Globally it costs an estimated $533 billion (Shaheen et
al., 2016). While there are other costs such as veterinary care and pre-mature culling,
mastitis inflicts its greatest impact through losses in milk production.
1.5. Oxidative Stress and Antioxidation
Oxidative stress occurs when the number of oxidants outnumbers the
antioxidative capacity of a tissue. A contributing factor in a multitude of conditions in
disease, oxidative stress arises from a multitude of sources and inflicts damage to the host
directly and indirectly. To combat these assaults, the antioxidative response is stimulated
through the forkhead box, class one (FOXO) and the kelch-like ECH-associated protein 1
(KEAP1) - nuclear erythroid 2-related factor 2 (Nrf2) signaling pathways (Klotz et al.,
2017; Plafker et al., 2010).
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1.5.1. Sources of Oxidative Stress
Superoxide is produced in the electron transport chain (ETC) of the mitochondria
in addition to enzymatic reactions, such as reactions by xanthine oxidase and those seen
in lysosomal degradation and peroxisome proliferation (Cerruti et al., 1985). The
mitochondrion contains its own DNA to maintain itself, but it is subjected to oxidative
damage when free radicals are produced from the ETC (Bhat et al., 2015). This damage
exacerbates the ROS issue because the damaged DNA impairs the mitochondrion’s
synthesis of ETC components and antioxidative components, such as superoxide
dismutase (SOD) (Bhat et al., 2015). Hydrogen peroxide, when provided iron in the case
of cytochrome-c or another source of electrons, can produce hydroxyl radicals via the
Fenton reaction with iron or form superoxide in the case of the Haber-Weiss reaction
(Fenton, 1894; Haber and Weiss, 1934).
ROS can also be produced as a result of the immune system. Concentrated ROS
are utilized in immune signaling and as a weapon by the cell against pathogens, which
leads to targeted destruction with collateral damage. The activation of the immune system
and inflammation stimulates inducible nitric oxide synthase to produce nitric oxide,
which is a potent signaling molecule that stimulates vasodilation (Lind et al., 2017).
Hydroxyl radicals are also produced by activated PMNs by the formation of
hypochlorous acid and peroxynitrite by myeloperoxidase (Prutz, 1996). The production
of free radicals from multiple sources adds up to a massive oxidative burden to the
microenvironment, thus the immune response often results in oxidative stress.
While ROS cause damage, they are naturally produced in the cell and are an
integral part of cellular signaling. Proteins, particularly cysteine and methionine
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containing proteins, are capable of being temporarily modified by ROS. Cysteine and
methionine contain sulfur groups that are easily oxidized to hydroxylated or nitrosylated
sulfur groups by ROS and RNS, respectively, and can be reverted to their previous form
by glutathione or other reducing equivalents (Filomeni et al., 2015). An example of this
nature is exemplified by glutathione when it is oxidized by a free radical and the now
oxidized glutathione dimerizes with another oxidized glutathione in oxidative conditions.
Another example of this control is seen in apoptosis regulated signaling kinase 1 (ASK1),
a regulator of JNK and p38. ASK1 under a balanced redox state is constantly inhibited by
reduced glutathione, but it becomes more and more activated by ROS as glutathione is
oxidized to combat the free radicals (Ray et al., 2012). While ROS are produced by
mitochondrial distress and immune actions, they are integral signaling molecules as well.
1.5.2. Implications of Oxidative Stress
Oxidative stress and its effects are mediated by oxidants, which can be classified
into 2 main classes: reactive oxygen species (ROS) and reactive nitrogen species (RNS).
ROS and RNS are each derived from oxygen. Oxygen itself is considered a radical, an
oxidant with an unpaired electron, along with superoxide, oxygen radical, hydroxyl, nitric
oxide, and nitrogen dioxide. The other main class of oxidants are non-radical species,
which are molecules prone to participate in free radical reactions, and some of these
molecules include hydrogen peroxide, singlet oxygen, hypochlorous acid, and
peroxynitrite. The nature of how these molecules promote oxidative stress differs from
molecule to molecule.
Superoxide can oxidize iron complexes like cytochrome C and can produce
perhydroxyl radical, which inflict lipid peroxidation (Cerruti et al., 1985). It is resolved
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by superoxide dismutase, where it is converted into oxygen diatom and hydrogen
peroxide (Bielski et al., 1996; Bielski et al., 1985). Hydrogen peroxide is eliminated by
catalase and glutathione peroxidase (Halliwell et al., 2000). Hydroxyl radicals are very
reactive and can inflict damage to carbohydrates, lipids, nucleic acids, and proteins. They
are also produced by activated PMNs by formation of hypochlorous acid by
myeloperoxidase (Prutz, 1996). Hypochlorous acid itself is involved in chlorination and
oxidation reactions that form chloroamines from amines and chlorohydrins from
cholesterol and unsaturated lipids (Prutz, 1996). PMNs can also form peroxynitrite,
which can further breakdown into hydroxyl radical and nitric oxide. Nitric oxide is lipid
soluble and is an integral signaling molecule that mediates vascular responses and
monitors redox state via protein nitrosylation of certain molecules (Wink and Micthell,
1998; Stamler, 1994)
DNA is highly susceptible to oxidative stress, particularly mitochondrial DNA as
it is in the environment of oxidative phosphorylation and increased metabolic activities
that promote oxidative stress. Hydroxyl radicals among others can cause single and
double stranded breaks in DNA and can abstract hydrogen to cause cross linking. Of all
the byproducts created by this destruction, 8-hydroxy-deoxyguanosine is utilized as a
marker of oxidative DNA damage (Barja et al., 2000). Peroxynitrite can perform both
oxidative and nitrative DNA damage via the production of 8-deoxyoxyguanosine and 8nitroguanosine, respectively (Hiraku, et al., 2010). In RNA, ROS attack is much more
common due to several factors: RNA is single stranded and more prone to breaks;
oxidized RNA cannot be reversed; there is little protective mechanism for RNA from
ROS unlike DNA; and RNA exists in the cytosol where ROS are used in signaling and
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generated as a byproduct from the mitochondria (Abe et al., 2002; Martinet et al., 2004).
The primary marker of oxidative damage to RNA is 7,8-dihydro-8-oxoguanosine and is
elevated in diseases like Alzheimer’s disease and atherosclerosis (Abe et al., 2002;
Martinet et al., 2004).
Lipids are susceptible to oxidation by free radicals, which is a process termed
lipid peroxidation. Particularly, the unsaturated bonds of monounsaturated fats like alphalinoleic acid and polyunsaturated fats such as arachidonic acid are reductive and attract
electrons (Mavangira et al., 2018). A lipid is oxidized when a hydrogen is abstracted to
form a lipid radical that reacts with diatomic oxygen to create a lipid peroxyl radical that
catalyzes the formation of endoperoxides. This leads to the formation of lipid
peroxidation’s toxic products malondialdehyde and 4-hydroxyl noneal (Bast et al., 1993).
Another class of oxidized lipids are isoprostanes, which are arachidonic acid derivatives
following peroxidation and are markers of oxidative damage (Aruoma, 1998). The
resulting impacts are not only damage to DNA and proteins, but also decreased
membrane fluidity, integral protein function, and propagation of the oxidative reaction to
other lipids.
Proteins are susceptible to all the ROS and RNS species listed previously (Dean et
al., 1997). Amino acids, particularly cysteine and methionine, are oxidized to form crosslinkages that ultimately denature proteins and inhibit their function (Butterfield et al.,
1998). Even though the sulfur-containing amino acids are more susceptible to oxidation,
their oxidation is reversed by the action of disulfide reductases and methionine sulfoxide
reductases. Markers of oxidative damage to proteins include 3-nitrotyrosine by RNS or
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O-tyrosine by OH- in addition to protein carbonyls in the case of arginine, lysine, proline,
and threonine (Chevion et al., 2000).
1.5.3. The Antioxidative Response
As stated earlier, oxidative stress is dependent on the balance between
generation of molecules capable of redox reactions and pathways to minimize their
generation. Any substance that delays or resolves oxidative damage to affected molecules
is known as an antioxidant. Antioxidants in mammals can be defined as either enzymatic
or non-enzymatic effectors. Of the enzymatic effectors, superoxide dismutase is the most
well documented with others like glutathione peroxidase, thioredoxin reductase, and
NADPH quinone reductase. These antioxidative enzymes are closely regulated by redox
signaling pathways. Particularly, the FOXO and KEAP1-Nrf2 signaling pathways are the
principal signaling pathways responsible for maintaining redox status.
FOXO is a class of transcription factors associated with the response to foreign
compounds. FOXO is upregulated by adverse cellular stress, such as oxidative stress, and
in a normal cell, FOXO is inhibited by PI3K/Akt signaling. Oxidative stress not only
inhibits PI3K/Akt signaling activation, but also promotes binding of FOXO to its
promoter, CREB-binding protein (CBP) and phosphorylation by JNK (Klotz et al., 2017;
Carter et al., 2008). Activation of FOXO leads increased synthesis of factors involved in
cell cycle arrest, cell death, DNA repair, glycolysis, and enzymes involved in
antioxidation like catalase (Klotz et al., 2017).
Like FOXO, Nrf2 is also upregulated by oxidative stress as well as PI3K/Akt
signaling. Nrf2 consists of 7 Nrf2-ECH domains (Neh1-7). Neh1 is a basic leucine zipper
that binds musculoaponeurotic fibrosarcoma protein (Maf) and ubiquitin-conjugating
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enzyme UbcM2 and binds to DNA (Plafker et al., 2010; Itoh et al., 1997). Nrf2 is
constitutively expressed and is regulated in 2 different manners: KEAP1-dependent or
KEAP1-independent. In the KEAP1-dependent mechanism, KEAP1 binds to motifs in
Neh2 domain of Nrf2 and recruits cullin-based E3 ubiquitin ligase to target Nrf2 for
polyubiquitination and proteasomal degradation (Hayes et al., 2010). In conditions of
oxidative stress, the cysteine residues on KEAP1, which bind to Neh2, are oxidized and
release Nrf2 (Hayes et al., 2010). KEAP1 may also be inhibited by p62 for lysosomal
degradation to stabilize Nrf2 (Komatsu et al., 2010, Lau et al., 2010).
KEAP1-independent Nrf2 regulation is mediated by glycogen synthase kinase 3
(GSK3), which phosphorylates serine residues on Neh6 motifs (Jain et al., 2010). This
primes beta-transducin repeat containing protein that recruits Skp1-Cul1-Rbx1/Roc1
ubiquitin ligase complex to target Nrf2 for proteasomal degradation (Copple et al., 2010).
Once Nrf2 is stabilized, it translocates to the nucleus and binds with Maf at Neh1 while
Neh4 and Neh5 bind to SRC-3 and cAMP-response-element-binding protein (Smith et
al., 2016). This complex initiates the transcription of target genes that contain antioxidant
response elements (AREs) in the promoter for amelioration of oxidative stress.
AREs are contained by a wide variety of genes that all play a role in antioxidation
on multiple levels. The major levels of response consist of enzymatic and soluble factor
expression to mitigate free radicals. Enzymatic breakdown of free radicals is performed
by heme oxygenase I (Hox1), NADPH quinone oxidase I (Nqo1) and other enzymes that
destroy free radicals, replenish antioxidants, and ameliorate damages incurred in the
tissue. Hox1 and Nqo1 are responsible for detoxification by neutralizing highly reactive
heme from damaged cells and quinone free radicals from oxidative phosphorylation,
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respectively (Ryter et al., 2016; Ross et al., 2017). Thioredoxin reductase is another
ARE-inducible gene that helps replenish reduced glutathione with the help of
cysteine/cystine transporter xCt, which provides thioredoxin reductase’s substrates for
glutathione synthesis (Mandal et al., 2010). AREs help the Nrf2 response operate in a
coordinated manner with expression of enzymes.
The second phase, meanwhile, indirectly controls free radicals by keeping cell
antioxidant capacity up with the oxidative burden via production of glutathione,
tocopherol, retinol and other soluble factors. While glutathione has been previously
noted, there are a wide variety of non-enzymatic antioxidants that possess the ability to
give or accept electrons. Tocopherols are the predominant antioxidant in cell membranes
as they can prevent the propagation of lipid peroxidation cascades (Mavangira et al.,
2018). Ascorbic acid also participates in antioxidation by acting directly on free radicals
and recycling other antioxidants as well (Yang et al., 2014). Lipoic acid is also a capable
antioxidant that chelates metal, sequestering it from pro-oxidants, as well as in recycling
dihydrolipoic acid (Baumgartner et al., 2017).
1.5.4. Oxidative Stress in the Mammary Gland
While the production of ROS is a natural part of signaling pathways and
metabolic activities, it can be thrown into oxidative stress with the reduction of
antioxidants. The mammary gland is no exception to this pathophysiology as total
antioxidant capacity is reduced in the mammary gland in diseases such as mastitis.
In humans and cows, it has been documented that the periparturient period
reduces the antioxidative capability of the mammary gland due to negative energy
balance, which leads to inefficient action by leukocytes that extends into early lactation
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(Abdelli et al., 2017). Because of negative energy balance, milk yield does not reach its

peak output until the late phase of early lactation (Zachut et al., 2016). High amounts of
oxidation can induce the mammary gland metabolism to shunt glucose away from
glycolysis. It was found in cattle that there is an inverse relationship between energy
balance and glucose 6 phosphate dehydrogenase, a rate limiting enzyme of the pentose
phosphate pathway, with early lactation being a time of great G6PDH activity (Zachut et
al., 2016). This potentially points to glucose funneling towards NADPH production,
which fuels enzymatic free radical quenching and antioxidant reduction (Zachut et al.,
2016).
There is a strong correlation between mastitis and a reduction in its damage with
supplementation of antioxidants, such as vitamin E and selenium (Allison and Laven,
2000; Smith et al., 1984; Smith et al., 1997). Supplementation of vitamin E and selenium
to cows increased the bactericidal behavior of macrophages in the mammary gland and
blood relative to untreated cattle (Grasso et al., 1990; Gyang et al., 1984; Hogan et al.,
1993). This may be due to the reduced adhesion and diapedesis of PMNs to the
endothelium in selenium treated cattle (Maddox et al., 1999). Serum vitamin A is reduced
in cows with clinical mastitis, and beta-carotene supplementation ameliorated the impact
of mastitis (Chew, 1995). In accordance with vitamin A, vitamin C concentration in
plasma decreases in mastitis afflicted cattle (Weis and Hogan, 2007). Cows with subacute
ruminal acidosis presented LPS in the bloodstream, which lowered the total antioxidation
capacity and expression of SOD1, SOD2, and GPx1 in bovine mammary gland tissue
(Memon et al., 2019). The presence and breakdown of polyunsaturated fatty acids
conjugated linoleic acid and docosahexaenoic acid, which can participate in free radical
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sequestration, in human MECs induces Nrf2 activation and upregulated NQO1 and HO-1
expression, respectively (Bang et al., 2017).
Antioxidants are just the soluble measures of free radical control. The KEAP1Nrf2-ARE antioxidant response pathway is a key component of the free radical balance
of the mammary gland. Key endocrine modulators in the lactating mammary gland have
shown to modulate Nrf2 signaling. Estrogen receptor alpha binding domain has been
shown to be essential in inhibition of NQO1 expression (Yao et al., 2010). Estrogen
related receptor beta overexpression in COS-1 cells has shown to reduce TBHQ-induced
Nrf2 activation (Zhou et al., 2007), and glucocorticoid receptors have been shown to be
inhibitors via interactions with the Neh4/5 domain of Nrf2 (Ki et al., 2005).
Overall, oxidative stress plays a central role in both normal signaling and immune
function while also being a key pathological characteristic in a plethora of diseases. The
ultimate consequence of free radical imbalance, oxidative stress can inflict damage to
proteins, fats, and nucleic acids, thus hindering cell function. The mammary gland has a
lot of interplay with oxidative stress, and while there are many soluble factors that can
impact the antioxidant response alongside Nrf2 signaling, mastitis tremendously
increases the free radical burden on the tissue to induce cell damage, death and reduced
milk production.
1.6. Hypoxia
Oxygen needs are well known for oxidative metabolism, but the demand for
oxygen differs within each tissue depending on metabolic rate, tissue location, and other
factors. When the amount of available oxygen decreases below normal limits in a tissue,
the hypoxic response is initiated to adapt the cell and tissue to this condition. The oxygen
- 43 -

content of a tissue can vary from as high as 21% in the lung to as low as 1% in the retina,
for example (Shao et al., 2014). When the oxygen tension of a tissue drops below its
minimum threshold, it activates hypoxia-inducible factor 1 (HIF-1) in an oxygen
dependent manner. HIF-1 is a heterodimeric transcription factor consisting of a
regulatory α-subunit and a β-subunit and both are constitutively produced. The former is
regulated in conjunction with oxygen tension as oxygen concentration controls the
activities of prolyl hydroxylases I-III (PHD) (Greer et al., 2012). PHDs under normal
oxygen conditions add hydroxyl groups to HIF-1α, which binds von Hippel Lindau
protein to induce polyubiquitination of HIF-1α and its subsequent degradation by the
proteasome (Greer et al., 2012). In hypoxic conditions, the PHDs are inhibited, thus the
transcription factor can bind to HIF-1β and transcriptional enhancer p300 followed by
translocation to the nucleus to act on hypoxic response elements (HREs) of genes. Some
notable HRE contained genes include glucose transporters, glycolytic enzymes and
lactate dehydrogenase for anaerobic metabolism and VEGF to encourage angiogenesis
for more oxygen delivery (Shao et al., 2014; Laukka et al., 2016).
While oxygen concentration is widely known to control HIF-1α, the inflammatory
response is also a potent activator. The inflammatory response activates hypoxic
signaling by HIF-1α at the gene and protein levels in an oxygen-independent manner.
Inflammatory signaling is regulated in part by NF-κβ transcriptional regulation, which
happens to directly control the gene expression of HIF-1α (Ge et al., 2019). At the
protein level, inflammation raises the oxidative stress of the affected tissue, and elevated
ROS have been shown to be inhibitors of PHD-mediated HIF-1α repression (Fitzpatrick
et al., 2018). Immune cells, which operate on a largely glycolytic metabolism, have high
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expression of HIF-1α relative to other cells, and HIF-1α expression is stimulated by LPS
treatment (Fitzpatrick et al., 2018; Ge et al., 2019).
Hypoxia signaling plays an important role in immune signaling, yet it has not
been explored as it relates to mastitis. The mammary gland has presented evidence that it
experiences increasing amounts of hypoxia from mid-pregnancy to early lactation in mice
(Shao et al., 2014). There may be a potential role that hypoxic signaling serves in
mammary development as HIF-1α expression varies throughout mammary development
and oxygen consumption increases from mid-pregnancy to early lactation (Shao et al.,
2014; Påhlman et al., 2015). While the change of the concentration of oxygen in the
mammary gland throughout a lactation is studied, the role of oxygen tension in mastitis
remains to be elucidated.
1.7. Summary and Study Aims
Mastitis costs the dairy industry $2 billion annually in the U.S.A. While it is
known that the major portion of this cost is due to a loss of production, the underlying
mechanisms are largely unknown. We hypothesized that mastitis induces localized
hypoxia in the mammary gland caused by leukocyte recruitment, which reduces overall
milk production along with the combined actions of elevating cell death and oxidative
stress and inhibiting milk gene expression. The specific aims were to examine the effects
of intramammary LPS challenge on cell apoptosis, oxidative stress, oxygen tension, and
milk protein gene expression in the mammary gland using a mouse model.
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2.1. Abstract
Mastitis, the inflammation of the mammary gland by bacterial infection, is one of
the costliest diseases to the dairy industry primarily due to a loss in milk production. The
aim of this study was to investigate the mechanisms underlying reduced milk production
during mastitis. We hypothesized that bacterial endotoxin induces cell apoptosis,
oxidative stress and increases hypoxia while inhibiting milk gene expression in the
mammary gland. To test this hypothesis, mice were bred to pregnancy, and 3 days postpartum the left and right sides of the 4th pair of mammary glands were alternately injected
with either the endotoxin liposaccharide (LPS, E. coli 055:B5, 100 ul of 0.2 mg/ml) or
sterile PBS through the teat meatus. At 10.5 and 22.5 h post-injection, pimonidazole HCl,
a hypoxyprobe, was injected intraperitoneally. At 12 or 24 h after the LPS injection, the
fourth glands were individually collected (n=8 pairs) and analyzed for hypoxia, gene
expression and oxidative stress. LPS treatment induced mammary gland inflammation as
shown by increases in inflammatory cytokine expression (P < 0.001) and neutrophil
recruitment at 12 and 24 h. LPS promoted cell apoptosis in a transient manner; an
abundance of cleaved caspase 3 was evident only at 12 h after LPS challenge (P = 0.02).
Increased H2O2 content was seen at 12 h (P < 0.001) but decreased dramatically after 24
h of LPS treatment (P < 0.001). Total antioxidative capacity tended to decrease at both 12
and 24 h (P = 0.067 and 0.061, respectively). In agreement with these findings, LPS
activated Nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidative signaling in the
mammary gland, demonstrated by increased expression of its target gene Nqo1 at 12 h (P
= 0.05) and xCT at 24 h (P = 0.076). Hypoxyprobe staining, indicative of hypoxia, was
greater in the alveoli of PBS-treated glands than LPS-treated glands at both 12 and 24 h.
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This suggests oxygen tension rises in response to LPS treatment. Conversely, milk
expression genes, β-casein gene (CSN2) and α-lactalbumin (LALBA), were inhibited by
LPS treatment across time. Expression of α-S1 casein (CSN1S1) mRNA increased with
LPS treatment at 24 h, but protein expression was reduced at this same time point (P <
0.05). In summary, intramammary LPS challenge incurs inflammation, augments cell
apoptosis, induces oxidative stress and activation of the Nrf2 antioxidation pathway,
increases oxygen tension, and inhibits milk protein expression in the mammary gland.
This study provides functional insight into mechanisms of reduced milk production
during mastitis and provides possible approaches to combat reduction in milk production,
such as enhancing the Nrf2-antioxidative signaling pathway and reducing inhibition of
milk protein expression.

Keywords:
Antioxidation, Gene expression, Hypoxia, Inflammation, Mastitis, Nrf2
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2.2. Introduction
Mastitis is a major economic challenge to the dairy industry. Mastitis is
inflammation of the mammary gland caused by bacterial invasion and infection. The
major reason for the economic loss is reduced milk production (Janzen et al., 1970;
Guimarães et al., 2017). Mastitis is characterized by many forms, from acute clinical
mastitis to chronic subclinical mastitis, as it is caused by a plethora of bacteria. Clinical
mastitis causes the mammary gland to become swollen and inflamed by vasodilation, and
it is often painful for the mother. In contrast, subclinical mastitis is often asymptomatic,
but still reduces milk yield. During mastitis, immune cell recruitment to the site of
infection enhances somatic cell count (SCC). Additionally, compromised mammary
epithelial cell (MEC) tight junctions permit increased sodium content in the milk (Leitner
et al., 2004). Together, SCC and sodium content in the mammary gland increase with
severity of mastitis, and milk yield decreases. Mastitis not only causes acute effects to the
cow, but it also leads to chronic issues. For example, milk production in animals with
resolved mastitis is much lower than unafflicted animals (Boscos et al., 1996; Dürr et al.,
2008, Wilson et al., 1995). In subclinical mastitis, the development of antibiotic
resistance adds costs to veterinary care and can result in premature culling
(Vanderhaeghen et al., 2010; Aslantaş et al., 2016; Hinthong et al., 2017).
The type of infection in mastitis is in part dependent upon the etiological agent.
Subclinical mastitis is most often caused by Gram-positive bacteria, whereas Gramnegative bacteria commonly cause acute clinical mastitis. Gram-positive bacteria that
cause mastitis include Staphylococcus aureus (S. aureus), Streptococcus agalactiae (S.
agalactiae) and Streptococcus uberis (S. uberis). These pathogens spread mostly by
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physical contact between animals and people, which is why it is considered contagious
mastitis. Gram negative bacteria, on the other hand, are usually spread through exposure
to fecal matter. These bacteria are often pathogenic strains of Enterobacteriaceae found
in mammalian gastrointestinal tracts, such as Escherichia coli (E. coli). These bacteria
are not as adept at evading the host immune system, and thus they are readily targeted for
destruction. The lysis of these bacteria by soluble factors like β-defensin triggers the
release of endotoxins such as lipopolysaccharide (LPS), a superantigen that
overstimulates the host immune system to cause acute inflammation, endotoxemic shock
and other symptoms of clinical mastitis (Bhattarai et al., 2018; Hagiwara et al., 2016).
Interestingly, heat inactivated E. coli activate pro-inflammatory signaling more strongly
than heat inactivated S. aureus (Bhattarai et al., 2018).
Bacterial infection in tissues initiates a cascade of innate immune responses.
Macrophages and MECs work in concert to recruit polymorphonuclear neutrophils
(PMNs), which in turn combat pathogens via phagocytosis and the expression of reactive
oxygen species. PMNs also secrete cytokines that support a pro-inflammatory and
antimicrobial environment. However, resolving the infection is not without costs. Tight
junctions of MECs are compromised by pro-inflammatory responses and PMN diapedesis
(Wang et al., 2017, Elazar et al., 2010). Other MECs undergo apoptosis (Xiao et al.,
2015; Nagasawa et al., 2017; Matsunaga et al., 2018). Because of the dramatic increase
in PMNs recruited to the infected areas, we hypothesized that mastitis may cause
localized hypoxia due to increased oxygen consumption by the PMNs.
Massive PMN recruitment also increases free radical production to unbalanced
levels, a pathological state known as oxidative stress. Bacterial toxins and the immune
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response work in concert to raise oxidative stress during infections, which stimulates an
antioxidative response. Soluble factors, such as glutathione and vitamin E, help to
immediately resolve oxidative stress, but the efficacy of these factors diminish as
oxidative stress increases (Mir et al., 2017; Aref et al., 2018). To restore the balance, the
nuclear erythroid 2-related factor 2 (Nrf2) - antioxidant responsive element (ARE)
pathway is activated, which also stimulates the synthesis of antioxidant enzymes, such as
heme oxygenase-1 (Hox1) and NAD(P)H quinone oxidoreductase 1 (Nqo1) (Wang et al.,
2017). Together, these factors reduce the oxidant content and reestablish redox balance.
Because of its impact to dairy industry, mastitis research has become an
increasingly progressive field as many look to the pathology of this disease and finding
therapeutic treatments to combat it. The most common approach to study mastitis has
been through an intramammary infusion of pro-inflammatory bacteria toxin using bovine
and rodent models (Hoeben et al., 2000; Jiang et al., 2018). Many studies utilize
vitamins, minerals, or known antioxidants to investigate their therapeutic potential to
prevent damage incurred by mastitis in cattle (Minuti et al., 2015) and in mice (Wang et
al., 2017). While they do not fully mimic all aspects of bovine lactation, mice and rats are
widely used as mastitis models because they are easier to maintain and they are cost
effective (Chandler, 1970). Importantly, the findings from rodent models of mastitis have
largely confirmed bovine phenomena (Chandler, 1970; Lee et al., 2003; Notebaert et al.,
2006; Breyne et al., 2015; Gogoi-Tiwari et al., 2017). Whereas most of these studies
have examined effects of potential therapeutics on inflammation, oxidative stress, and
apoptosis in the mammary gland, studies investigating the effects of bacterial toxins on
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milk protein expression are limited, and no study to our knowledge has examined oxygen
tension in the mammary gland during mastitis.
The objective of this study was to investigate the time-dependent effects of
bacterial LPS challenge on oxygen tension, oxidative stress, and expression of milk
protein genes and genes involved in these pathways in the mammary gland using a mouse
model. Our study showed that LPS incurs inflammation, augments cell apoptosis, induces
oxidative stress and activation of the Nrf2-ARE antioxidation pathway, increases oxygen
tension, and inhibits milk protein expression in the mammary gland. All of these effects
likely contribute to the decrease in milk production during mastitis.
2.3. Materials and Methods
2.3.1. Animal Treatment and Tissue Isolation
Sixteen 8-week-old female BALB/cJ mice (Jackson Labs, Bar Harbour, ME) were
used for this study, and all procedures of animal use were approved by the University of
Vermont Institutional Animal Care and Use Committee (IACUC Protocol #17-030).
Mice were kept in breeding cages in harems of 1 male and 2 females under a controlled
environment (25˚C, 45% humidity and 12 h light-dark cycle) and were bred to
pregnancy. Three days postpartum, all lactating mice were anesthetized with 4.0%
isoflurane and then received an intramammary infusion (IMI) of either
lipopolysaccharide (LPS, E. coli 055:B5, #6529, Sigma, St. Louis, MO; 100 µL of 0.2
mg/mL) or sterile PBS (100 µL), alternatively into either side of the 4th mammary glands
through the teat meatus with 30G 0.5 mL insulin syringes (Becton, Dickinson &
Company, Franklin Lakes, NJ), and the injection site was thoroughly and gently
massaged. At 10.5 and 22.5 h post-IMI, 1.5 mg/mL pimonidazole HCl (#HP2-1000 kit,
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Hypoxyprobe, Burlington, MA) in sterile water was injected intraperitoneally (i.p.) into
each mouse at 4 µL per gram body weight. At 12 or 24 h after the LPS infusion, eight
mice were euthanized by cervical dislocation to maintain oxygen tension in the
microenvironments of the tissues. The 4th glands were individually collected immediately
from all animals (n=8), and tissue samples were either snap-frozen in liquid nitrogen and
later stored in -80ºC or chemically fixed as described below.
2.3.2. RNA Isolation, Reverse Transcription (RT) and Real-Time Quantitative
Polymerase Chain Reaction (qPCR)
Frozen mammary tissue was weighed to 30 mg, dispersed and ground by mortar
and pestle chilled in liquid nitrogen. Ground tissue was placed directly into 600 µL of
lysis buffer (RLT, Qiagen, Venlo, Netherlands) with 1% β-mercaptoethanol (#M6250100 mL, Sigma) and was homogenized by an electric homogenizer in 3 x 10 s bursts with
10 s in ice between bursts to avoid rise in temperature. Total RNA was then isolated
using RNEasy Mini Kit (#74104, Qiagen) according to the manufacturer’s instruction.
Total RNA was treated with DNAse I (#79254, Qiagen) and eluted in ultrapure water.
The RNA concentration and quality were evaluated by Nanodrop 2000
spectrophotometric analyzer (#ND-2000, Thermo-fisher, Waltham, MA), and RNA
quality was further analyzed by Agilent 2100 Bioanalyzer (Agilent, Santa Clara, CA) at
the Vermont Integrated Genomics Core (Burlington, VT) to verify RNA Integrity
Number values ≥ 8.0.
cDNA synthesis was performed using Invitrogen SuperScript III cDNA Synthesis
Kit (#18080051, Invitrogen, Waltham, MA) according to manufacturer’s specifications in
an Applied Biosystems 2720 Thermocycler (#4359659; Applied Biosciences, Waltham,
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MA). RNA samples were diluted to 2 µg for 8 µL reaction with ultrapure grade water
with 1 µL each of provided dNTP mix and Oligo(dt-20). Samples were denatured at 85ºC
for 5 min and then added with 10 µL of SuperScript III reaction mix. Reactions were
performed at 50ºC for 50 min, 85ºC for 5 min and at 4ºC for 5 min. Reactions were
collected by brief centrifugation for 1 min at 18,000 x g and 1 µL RNAse H was added to
each reaction and incubated at 37ºC for 20 min before stored at -20ºC.
mRNA expression was determined by qPCR using iTaq SYBR Green Supermix
(#1725121, Bio-Rad, Hercules, CA). 1 µL of cDNA solution was mixed with 500 nM
forward and reverse primers (Table 1) in 10 µL, and 10 µL of iTaq SYBR Green
Supermix was added to each reaction. The reactions were carried out in Bio-Rad CFX96
Thermocycler using the following program: initial denaturation at 95ºC for 30 s and 40
cycles of 5 s at 95ºC for denaturation and 30 s at 60ºC for annealing and extension
followed by melt curve analysis from 65-95ºC at 0.5ºC increments at every 5 s. The
qPCR data was analyzed by 2^^ (-ddCt) method (Livak, 2001) and normalized by the
expression levels of the housekeeping genes ActB, Hprt, Gapdh, Stx5a, and hnRnpab.
Specificity of primers was further assessed by the Vermont Integrated Genomics Core.
2.3.3. Protein Isolation and Western Blot
200 mg of frozen mouse mammary tissue was lysed in 1,500 µL NP-40 lysis
buffer (#FNN0021, Fisher, Waltham, MA) with protease inhibitor cocktail (#8340,
Sigma) and pulverized by Dounce homogenizer at 4ºC. Whole tissue lysates were then
agitated at 4ºC for 2 h and centrifuged at 13,400 x g for 20 min at 4ºC. Supernatants were
divided into aliquots and stored at -80ºC. Concentration of tissue lysates was determined
by the Bradford Colorimetric assay (#5000001, Bio-Rad) with bovine serum albumin
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(BSA) protein standard (#500-0007, Bio-Rad). Based on these concentrations, tissue
lysates were diluted in lysis buffer to achieve a volume of 300 µL before addition of 100
µL 4X Laemmli buffer [62.5 mM Tris-HCl, pH 6.8, 10% glycerol, 2% sodium dodecyl
sulfate (SDS), 0.00125% (weight/volume) bromophenol blue] for a final protein
concentration of 3.33 µg/µL. Samples were vortexed and immediately placed in 100ºC
heat block for 10 min.
15 µL samples were loaded into gels for SDS-polyacrylamide gel electrophoresis
(SDS-PAGE) (Stacking gel: 0.125 M Tris-HCl, pH 6.8, 0.05% ammonium persulfate,
0.1% TEMED, and 4% SDS-polyacrylamide; Separating gel: 1.5 M Tris-HCl, pH 8.3,
0.05% ammonium persulfate, 0.05% TEMED, and 12% SDS-polyacrylamide) and ran at
150 V in electrode buffer (1.5% Tris base, pH 8.3, 7.2% glycine, and 0.5% SDS) until the
dye front reached the end of the gel. The separated proteins were transferred to
polyvinylidene fluoride membranes at 95 V and 4ºC for 90 min with transfer buffer (25
mM Tris, pH 8.3, 192 mM glycine, and 20% methanol), and the blots were stained with
1% ponceau S solution to evaluate protein transfer efficiency. Blots were blocked in 5%
BSA in Tris-buffered saline with 0.1% Tween-20 (TBS-T, #P1379, Sigma).
Blots were incubated overnight on a plate shaker at 4ºC with primary antibody for
β-Casein (#sc-166684, Santa Cruz Biotechnology, Santa Cruz, CA; 0.2 ug/mL), α-S1Casein (#sc-365929, Santa Cruz Biotechnology; 0.2 ug/mL), α-Lactalbumin
(#abx101423, Abbexa, Cambridge Science Park, Cambridge, United Kingdom; 0.2
ug/mL), and Cleaved Caspase 3 (#CST-9661, Cell Signaling, Danvers, MA; 1:1000).
Blots were washed 3 times with TBS-T for 10 min intervals followed by incubation with
secondary antibodies [goat horseradish peroxidase (HRP)-linked anti-rabbit IgG: #CST-
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7074P2, Cell Signaling; Goat HRP-linked anti-mouse IgG: #sc-2005, Santa Cruz
Biotechnology] at 1:10,000 dilution and room temperature for 1 h (Santa Cruz
Biotechnology). Blots were then washed 4 times in TBS in 10 min intervals before
incubation with ECL-substrate solutions (#34577, Invitrogen). Blots were then imaged
with ChemiDoc ECL Imager (Bio-Rad), stripped for 15 min in Restore western blot
stripping buffer (#21063, Invitrogen), and reprobed with antibody for GAPDH (#2118,
Cell Signaling; 1:5000). Optical density of images was evaluated by ImageJ (Java-based
image-processing and analysis software, ver. 5.12a; National Institute of Health,
Bethesda, MD; Gallo-Oller et al., 2018) and normalized by the expression of GAPDH.
2.3.4. Histological Staining and Immunohistochemistry
Fresh mouse mammary tissue was cut into 3-5 mm pieces and either fixed in 4%
paraformaldehyde and embedded in optimal cutting temperature (OCT) compound or
fixed in 10% formalin and embedded in paraffin. For OCT embedding, fresh tissues were
washed 3 times in ice cold sterile PBS and immersed in PBS with 4% paraformaldehyde
at 4ºC for 4 h. After 3 washes in ice cold PBS, the tissue pieces were immersed in 0.5 M
sucrose in PBS at 4ºC overnight, embedded in OCT compound, and then stored at -80ºC.
For paraffin embedding, tissue pieces were fixed in neutral buffered PBS with 10%
formalin (#HT501128, Sigma) at room temperature for 4-6 h and stored in 70% ethanol
at room temperature. Tissue embedding, deparaffinization, sectioning, hematoxylin and
eosin staining were performed by the Pathology Department of the University of
Vermont Medical Center (Burlington, VT).

Immunostaining of mammary tissue was performed as per the literature
(Choudhary et al., 2018) with modifications. Briefly, 5 µm thick tissue sections were
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deparaffinized in xylene (3 x 5 min) followed by dehydration in absolute ethanol (2 x 3
min), gradual rehydration of tissue sections in 95% ethanol (2 x 3 min), 70% ethanol and
deionized water (2 x 2 min). Antigen retrieval was done on hot plate for 10 min in boiling
citrate buffer at pH 6.0 (Vector lab, Burlingame, CA) followed by 30 min of cooling at
room temperature. Slides were washed in PBST (PBS with 0.5% of tween 20). After
blocking non-specific protein binding with 2.5% horse serum (Vector lab) for 20 min,
slides were incubated with FITC conjugated anti-pimonidazole mouse IgG1 monoclonal
antibody (1:100 dilution in 2.5% horse serum; Hypoxyprobe™ Plus Kit, Hypoxyprobe,
Inc., Burlington, MA) for 1.5 h at room temperature in moist chamber. Slides were
washed with PBST (3 x 2 min) before mounting with Vectashield with 4,6-diamidino-2phenyl-indole (DAPI) (Vector Lab). Slides were viewed with a fluorescence microscope
(model Eclipse 50xi, Nikon Instruments Inc. NY,) at 200X magnification under green
(FITC) and blue (DAPI) channels.

Five to seven images/slide were captured from LPS- and PBS-treated glands
under constant illumination. Images were opened in ImageJ (ver. 5.12a), and inner and
outer boundaries of alveoli were marked using freeform drawing tool. From each image,
12 distinct and intact alveoli were marked and measured for AREA, INTEGRATED
DENSITY, STANDARD DEVIATION and MEAN GRAY VALUE of hypoxia signal
using freeform drawing tool. The difference in raw integrated intensity of outer and inner
boundary of alveoli provided the mean integrated intensity of hypoxia probe signal of
mammary epithelium.
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2.3.5. Oxidative Stress and Antioxidation Assays
Hydrogen peroxide (H2O2) levels in mammary tissues were analyzed using Sigma
Fluorimetric Hydrogen Peroxide Assay Kit (#MAK166) according to manufacturer’s
specifications. Briefly, protein lysates from Western blot analysis were diluted to 1
mg/mL in NP-40 lysis buffer without protease inhibitors to avoid downstream
interference of the assay. In 96 well plates, 50 µL of each samples and standards of 0,
0.1, 0.3, 1, 3, and 10 uM H2O2 was laid out and each reaction was mixed with 50 µL
reaction mixture consisting of assay buffer with 20 units/mL horseradish peroxidase and
1% infrared fluorometric peroxidase substrate. Plates were incubated at room temperature
(23ºC) for 10 min and then read fluorometrically at 640 nm excitation/680 nm emission
on a H4 Plate Reader (Biotek Synergy, Winooski, VT). Fluorescence of standards were
utilized to form a standard curve and average fluorescence of samples and their dilution
factor were used to quantitate the amount of H2O2.
Mammary gland total antioxidant capacity was analyzed using Sigma Antioxidant
Assay Kit (#CS0790) according to manufacturer’s specifications. Approximately 100 mg
tissue was lysed in Dounce homogenizer in Assay Buffer at 4ºC. Lysates were
centrifuged at 12,800 x g at 4ºC for 15 min, and the supernatants were collected and
aliquoted. For each reaction, 10 µL 10 µg/mL tissue lysate was mixed with 10 µL horse
myoglobin in ultrapure water. Standard curve was prepared with (±)-6-Hydroxy-2,5,7,8tetramethylchromane-2-carboxylic acid (Trolox) at 0, 0.015, 0.045, 0.105, 0.21, and 0.42
mM, respectively. Before adding reaction buffer, 25 uL 3% H2O2 was mixed with 10 mL
ABTS buffer to activate the reagent. To each reaction in a 96 well plate, 150 µL ABTS
reaction buffer with H2O2 was added to reactions and incubated for 5 min at room
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temperature (23ºC). 100 µL stop buffer was added, and plate was read for optical density
at 405 nm in a Biotek Synergy 2 Plate Reader. The total antioxidant capacity of tissue
samples was derived from the standard curve derived from the absorbance of the
standards and the dilution factor of the sample.
2.3.6. Statistical Analysis
All the data were analyzed by two-way mixed ANOVA using PROC MIXED
model in SAS (ver. 9.4; SAS Institute, Cary, NC). Time (12 and 24 h) and treatments (LPS
and PBS) and side of treatment (Left or Right) fixed factors each at two levels. Animal and
time were not repeated as each animal was euthanized for tissue collection, and different
groups of animals were used at two time points. The effects of intramammary treatments
(LPS and PBS) were observed over time, thus treatment was considered a repeated
measure. Observations for each variable were the dependent variables in the model. Effects
of animals were considered as random effects. Differences in means of each variable were
detected by type 3 tests for fixed effects (treatment and time) and interactions
(time*treatment). Data are expressed as mean ± SEM, and the differences between means
were declared significance (P < 0.05) or with a tendency of significance (0.05 < P < 0.10).
2.4. Results
2.4.1. LPS Incurs Inflammation
Hematoxylin and eosin staining of tissue sections showed that at 12 h of treatment,
intramammary challenge of LPS induced massive recruitment of cells, likely PMN based
on cell morphology (Elazar et al., 2010), into alveoli compared to PBS challenge (Figures
1A and 1B), and this recruitment was also evident at 24 h of LPS treatment (Figures 1C
and 1D). Moreover, mRNA expression of inflammatory cytokines IL-1B, IL-6, and TNF- 59 -

α was dramatically induced in the mammary gland by LPS at both 12 and 24 h (P <
0.05), but no difference was seen across time (Figures 1E-1G & Table 2).
2.4.2. LPS Induces Mammary Apoptosis
The effect of LPS on mammary gland apoptosis was investigated by the analyses
of proapoptotic marker expression. Compared to PBS treatment, LPS did not affect
mRNA expression of either caspase 3 or caspase 9 at 12 h and 24 h (Figures 2A & 2D,
Table 3), but expression of cleavage-activated caspase 3 (CC3) protein was significantly
increased (1.33-fold) within 12 h (P = 0.02, Figures 2B & 2C). LPS also increased
mRNA expression of Bax by 4.3-fold at 12 h (P = 0.001), but had no effect at 24 h
(Figure 2E, Table 3). Expression of the endoplasmic reticulum (ER) stress marker, Chop,
was not affected by LPS at 12 h, but decreased dramatically at 24 h (P = 0.006, Figure
2F). Expression of Bax and Chop exhibited a time and treatment interaction (P < 0.05,
Tables 2 & 3). Surprisingly, the mRNA expression of caspases 3 and 9 and Bax showed a
side difference of the glands and particularly, expression in the left side presented an
interaction with treatment in caspase 9 (P < 0.05, Table 3). No significant differences
were observed in the expression of Bcl2, CytS, and Bid mRNA between the two
treatments at any time (Figures 2G-2I & Table 2).
2.4.3. LPS Elevates Oxidative Stress and Stimulates the Antioxidative Response
LPS treatment induced oxidative stress in the mammary gland at 12 h,
demonstrated by an increase (1.8-fold) in tissue H2O2 levels compared to PBS treatment
(P < 0.001, Figure 3A). This effect diminished, however, by 24 h (P < 0.001, Figure 3).
Total antioxidative capacity (TAC) of the mammary gland tended to be lower at both 12
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(P = 0.066) and 24 h (P = 0.061) following LPS treatment (Figure 3B & Table 2). These
dynamics also demonstrated a time and treatment-dependent interaction (P < 0.05, Table
2).
LPS did not affect expression of Nrf2 mRNA, a master regulator of the
antioxidative response in the mammary gland, at either 12 or 24 h (Figure 3C & Table 2).
However, it did increase expression of the Nrf2 target gene, Nqo1, at 12 h (P = 0.050,
Figure 3D), and tended to increase expression of cystine transporter, xCt, at 24 h (P =
0.076, Figure 3E). In contrast, LPS tended to decrease expression of Hox1 mRNA at 24 h
(P = 0.056, Figure 3F). There was time by treatment interaction in terms of Nqo1 and
Hox1 mRNA expression, and Hox1 expression differed between the two sides of the
mammary tissue (P < 0.05, Tables 2 & 3).
2.4.4. LPS Increases Oxygen Tension in the Mammary Gland
To investigate whether LPS induces a hypoxic condition in the mammary gland,
we injected LPS-treated mice with the hypoxyprobe pimonidazole HCl, which binds to
amino acids and proteins under hypoxic conditions. To our surprise, fluorescent staining
of pimonidazole adducts showed that LPS did not induce hypoxic conditions in the
mammary gland at either 12 or 24 h (P < 0.05) (Figures 5A-D & Table 2). Expression of
Hif1a and Slc2a1 mRNA (hypoxia-induced genes) were not affected by LPS infusion,
although Slc2a1 expression increased at 24 h compared to 12 h (Figures 5E-F).
2.4.5. LPS Reduces Milk Protein Gene Expression
Compared to PBS-treated glands, mRNA expression of milk protein genes Csn2
and Lalba in LPS-treated glands was decreased at both 12 h (68% and 59% of control,
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respectively; P < 0.05) and 24 h (39% and 47% of control, respectively; P < 0.05)
(Figures 4A & 4B). In contrast, mRNA expression of Csn1s1 was not affected by LPS at
12 h but increased by 24 h (P = 0.013) (Figure 4C, Table 2).
At the protein level, expression of all three major milk proteins was inhibited by
LPS at 12 and 24 h (P < 0.05), except there was no effect on Csn1s1 at 12 h (Figures 4DG; Tables 2 and 3). A time by treatment effect of LPS on Csn1s1 protein expression,
however, was evident (P < 0.05, Table 2). Lalba protein expression differed between the
two sides of the mammary gland (P = 0.009; Table 3).
2.5. Discussion
The overall objective of this study was to investigate how mastitis causes a
reduction in milk production. To approach this goal, we studied the time-dependent
effects of the major bacterial endotoxin LPS on inflammation, apoptosis, oxidative stress,
oxygen tension, and milk protein gene expression in the mammary gland using a mouse
model. In this model, the fourth pair of mammary glands were unilaterally challenged
with either LPS or PBS through the teats. The major advantage of this model is the higher
power in statistical analysis due to the use of both treatment and control in the same
animal (McFadden et al., 1987); whereas a potential weakness is the possibility of
systemic effects of LPS. Although we cannot rule out the possibility that LPS injected to
one gland might enter the blood stream and travel to the opposite gland, effects were
minimal because cytokine expression and PMN recruitment remained low in the PBStreated gland. Interestingly, there was a location effect in terms of caspases 3 and 9, and
Bax. This effect has not been reported previously, to our knowledge, and its nature is not
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known. Nevertheless, for most of our analyses, relative location of LPS infusion did not
have an effect.
We utilized LPS as a pro-inflammatory endotoxin produced by the common
mastitis pathogen E. coli as it has been commonly used in a plethora of intramammary
infusion studies. The inflammatory responses induced by LPS have shown no difference
from live bacteria inoculations in both bovine and murine models (Hoeben et al., 2000;
Breyne et al., 2015). We used smooth LPS (sLPS), rather than rough LPS (rLPS), in this
study because the common gram-negative causative agents of mastitis produce smooth
LPS (Hinthong et al., 2017; Jiang et al., 2018). Some studies have compared the effects
of each type of LPS on MEC in vitro and in vivo and found that rLPS greatly induced
inflammation in vitro, but sLPS produced a pronounced, sustained response in bovine
mammary gland in vivo (Védrine et al., 2018). This is potentially due to more CD14
targeting the larger O-antigen of sLPS to promote TLR4 signaling. Indeed, previous
studies have also indicated that sLPS challenge greatly induces CD14 expression in
MECs in a dose dependent manner (Zheng et al., 2006).
As expected, intramammary LPS challenge in this study incurred mammary
inflammation, demonstrated by a large increase of PMN infiltration into the alveolar
lumen. Recruitment of PMN by LPS has been well shown in bovine and mouse
mammary glands in previous studies (Zheng et al., 2006; Elazar et al., 2010). This
recruitment results in a large increase in somatic cell count (SCC) in milk and is induced
by inflammatory mediators, including cytokines IL-1B, IL-6 and TNF-a, from
macrophages and MECs (Elazar et al., 2010). The surge of expression of cytokines in the
mammary gland by LPS challenge is also confirmed in this study.
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In this study, mammary infusion of LPS significantly induced protein abundance
of CC3 at 12 h, but not at 24 h, indicating a transient induction in cell apoptosis. Caspase
3 is a key death protease which plays a central role in the execution-phase of cell
apoptosis by catalyzing the specific cleavage of many key cellular proteins (Yang et al.,
2016; Fan et al., 2016). This enzyme is activated in the apoptotic cells both by death
ligand-mediated and mitochondria-mediated pathways, and the activation of this enzyme
requires proteolytic processing at conserved aspartic residues to produce two subunits
(Yang et al., 2016). The cleaved active form of caspase 3 is a widely used marker of cell
apoptosis. In supporting caspase 3 activation, mRNA expression of another popular cell
apoptosis marker gene Bax showed the similar changes by LPS in this study. Bax forms a
heterodimer with Bcl2 to activate cell apoptosis (Santos et al., 2018). These observations
were consistent with the observations from a previous study in which intramammary
infusion of LPS increased Bax expression at the mRNA and protein levels and caspase 3
cleavage at 12 h, but not caspase 3 gene expression (Song et al., 2014). Induction of cell
apoptosis by LPS were also observed by TUNEL assay in mouse and bovine mammary
tissue treated with LPS (Gao et al., 2016; Magro et al., 2017).
In this study, mRNA expression of an ER stress marker, Chop, is not increased at
12 h, but is decreased at 24 h following LPS challenge. Chop is a primary signaling
proteins behind ER-stress induced apoptosis when the unfolded protein response is
unable to resolve the source of stress (Oyadomari et al., 2003). The Chop depression at
24 h may suggest a dramatic improvement of anti-ER stress responses or a decrease of
ER stress after 24 h. This observation also supports a possible decrease in cell apoptosis
at 24 h in LPS infused glands.
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Consistent with CC3 expression, LPS induced a temporary increase in oxidative
stress in the mammary gland at 12 h, demonstrated by increased H2O2 level. Hydrogen
peroxide is a natural metabolite and a signaling molecule in many organisms, but its
overproduction by inflammatory and vascular cells during pathological conditions or over
accumulation due to decreased antioxidation capacity can induce oxidative stress (Jia et
al., 2019; Biswal et al., 2019). Milk from cattle with subclinical mastitis contains
pronounced H2O2 content (Atakisi et al., 2010). Hydrogen peroxide is the product of
superoxide and hydroxyl radical breakdown by enzymes like Sod1 and Nqo1, whose
activities are increased by circulating LPS (Memon et al., 2019; Han et al., 2018). The
accumulation of ROS can have destructive effects on cellular proteins, carbohydrates,
lipids, and DNA to impair their functions and initiate apoptosis. In fact, it is widely
documented that H2O2 can stimulate cell death in vitro by activating p53/Bax/Caspase 3
proapoptotic pathways in bovine MECs (Jin et al., 2015; Li et al., 2018).
However, the H2O2 level was largely decreased at 24 h of LPS treatment,
suggesting a release and improvement of oxidative stress. This decrease was likely due to
decreased production of ROS at this time because the TAC in the mammary gland tended
to be decreased at both times after LPS challenge. This is also supported by our
histological analysis which indicated reduced lymphatic cell infiltration, a major source
of H2O2, into the mammary gland and is consistent with the Chop expression. The
reduction of TAC by LPS or mastitis has been shown in previous studies. For example,
cattle with subclinical mastitis showed lowered TAC with increased SCC in milk (Atakisi
et al., 2010). Even increased LPS content in the plasma significantly lowered the TAC of
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mammary tissue of cattle experiencing subacute ruminal acidosis incurred by a highconcentrate diet (Memon et al., 2019).
Nrf2 is a key regulator of antioxidation. During oxidative stress, it is activated by
releasing from its binding with KEAP1 and then entering the nucleus to bind to the ARE
in the upstream promoter of many antioxidative genes, including Nqo1, xCt, Hox1, and
Txnrd1 (Nguyen et al., 2003; Wible et al., 2018). To study its potential role in mastitis,
we analyzed its expression as well as expression of its several target genes in this study.
LPS did not change Nrf2 mRNA levels but upregulated the expression of Nqo1 at 12 h
and tended to increase the expression of xCT at 24 h. Nqo1 and Hox1 are enzymes which
breakdown ROS into water and oxygen (Agarwal et al., 2001; Ross et al., 2000). Our
observations of gene expression of Nqo1 and Hox1 were consistent with the observation
in LPS challenged bovine MECs in which Nqo1 expression was greatest induced at 12 h,
whereas Hox1 was induced at only 4 h after the LPS challenge (Jin et al., 2015). The
cysteine/cystine transporter xCt is required for the synthesis of the antioxidant
glutathione and is Nrf2- and NF-kB-inducible with the latter being activated by ROSinduced ERK signaling (Lewerenz et al., 2012). Expression of xCt was greatly induced
by LPS in primary bovine MEC cultures at 12 h, but less so at 24 h (Jin et al., 2015). It
was shown that xCt activates MAPK following cystine supplementation to reduce effects
of LPS-stimulated sepsis in mice via MAPK-dependent IL-10 anti-inflammatory
signaling (Tanaka et al., 2015). Taken together, our observations indicated an activation
of Nrf2-ARE pathway by LPS.
We originally hypothesized that the large recruitment of PMN to the mammary
gland during mastitis could result in a local hypoxia. To test this hypothesis, we injected
- 66 -

LPS treated mice with the hypoxyprobe pimonidazole HCl which binds to amino acids
and proteins in hypoxic regions. To our surprise, histochemical staining using FITC
conjugated specific antibody to pimonidazole adducts in hypoxic cells showed that the
MECs in LPS treated gland even had a higher oxygen tension than in the PBS treated
gland. A hypoxic condition in the MECs at early lactation was demonstrated in our
previous study (Shao et al., 2014). We suspect that the improved hypoxic condition by
LPS treatment observed in this study at 12 and 24 h was probably due to 1) increased
blood supply to the region with inflammation, and 2) reduced oxygen utilization in MECs
resulted from a metabolic shift to anaerobic metabolism and reduced milk synthesis. LPS
has been shown to increase the expression of vascular endothelial growth factor in MECs
in vitro and in vivo (Minuti et al., 2015; Li et al., 2014; Devraj et al., 2017). However,
mRNA expression of Hif1α and its target gene Slc2a1 was not affected by LPS treatment.
This was probably because the function of HIF-1α is mainly regulated at the protein level
(Masoud et al., 2015; Devraj et al., 2017). There was a dramatic increase of GLUT1
expression at 24 h compared to 12 h in both treatment groups. This large increase over
time may point to a potential effect of milk stasis as milk removal has not occurred in 24
h in these animals. This may result in cell differentiation towards autophagic behaviors,
which promotes the expression of GLUT1 on the cell surface (Roy et al., 2017).
In this study, mRNA or protein expression of Csn2 and Lalba were significantly
decreased at 12 and 24 h by LPS treatment. Although the mRNA expression of α-S1caisin was elevated by LPS at 24 h, its protein expression was significantly inhibited by
LPS at 24 h. These observations indicated that LPS inhibits milk protein synthesis in the
mammary gland. The down-regulation of Csn2 and Lalba transcription by LPS is
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possibly mediated by LPS-induced NF-κβ and cytokine production. It has been shown
that LPS treatment of bovine MECs decreases phosphorylation of mTORC1 and its
targets like ribosomal S6 kinase 1 (Liu et al., 2015), which leads to the activation of NFκβ (Zhang et al., 2016). NF-κβ activation has also been shown in previous mouse mastitis
models (He et al., 2015; Jiang et al., 2018). NF- κβ activation has been shown to decrease
prolactin receptor mediated STAT5a phosphorylation, and the Csn2 gene promoter in
rodents and cattle have a consensus NF- κβ binding sequence that overlaps the STAT5a
binding site (Doppler et al., 2002; Geymayer et al., 2000; Malewski et al., 1995). The
decrease in phosphorylation of mTORC1 and its targets like ribosomal S6 kinase 1 can
also inhibit the overall gene translation. Moreover, reduced Lalba expression can result in
milk yield decrease because of its role in regulating lactose synthesis which control milk
osmolality (Habib et al., 2017).
In summary, LPS challenge greatly induced inflammation in the mammary gland.
Expression of CC3 and Bax pointed to a caspase 3 activation and potential increase in
cell apoptosis by LPS, but apoptotic signals were greatly reduced by 24 h. In addition, a
oxidative stress was transiently increased by LPS infusion at 12 h, accompanied by
enhanced expression of Nrf2 targeted antioxidative genes. Furthermore, LPS inhibited
milk protein gene expression, but improved hypoxic condition in the mammary gland.
These observations suggest that increased cell apoptosis due to oxidative stress, changed
MEC metabolism, and reduced milk protein gene expression may all contribute to the
decrease in milk production during mastitis.
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Table 1: Primers used in reverse transcription-PCR

Gene
Symbol

GenBank
Accessio
n
Number

Product
Length
(bp)

Csn1s1

NM_00
7784.3

193

Csn2

NM_00
1286022
.1

330

Gapdh

NM_00
1289726
.1
NM_01
0679.1

134

Slc2a1

NM_01
1400.3

361

Actb1

NM_00
7393.5
NM_01
3556.2
NM_00
8361.4
NM_00
1314054
.1
NM_00
1278601
.1
NM_00
9741.5
NM_00
7808.5
NM_00
1313920
.1

334

Lalba

Hprt
IL-1β
IL-6

TNFA

Bcl-2
Cycs
Hif1a

Primer Sequence (5’→3’)*

F: CCTTTCCCCTTTGGGCTTAC
R: TGAGGTGGATGGAGAATGGA

106

76
69
73

149

205
133
135

Reference

Kobayashi et al.,
2013

F:
CTTCAGAAGGTGAATCTCATGG
G
R:
CAGATTAGCAAGACTGGCAAGG
F: GAGCGAGACCCCACTAACATC
R: GCGGAGATGATGACCCTTTT
F: ACCAGTGGCTACGACACAC
R:
CGGGGAACTCACTACTTTTACAC
F:
RabanedaCTTCGCCCTGGCCCTGCAGGAG
Lombarte et al.,
C
2018
R:
GGCACCCCCCTGCCGGAAGCCG
GA
F: TGGAATCCTGTGGCATCCA
R: TAACAGTCCGCCTAGAAGCA
F: CCCCAAAATGGTTAAGGTTGC Aerni-Flessner et
R: AACAAAGTCTGGCCTGTATCC
al., 2012
F: GCACACCCACCCTGCA
Skelly et al.,
R: ACCGCTTTTCCATCTTCTTCTT
2013
F:
TCCAGAAACCGCTATGAAGTTC
R: CACCAGCATCAGTCCCAAGA
F: CTCCAGGCGGTGCCTATG
R:
GGGCCATAGAACTGATGAGAGG
F: GTGGTGGAGGAACTCTTCAG
R: GTTCCACAAAGGCATCCCAG
F: GAGGCAAGCATAAGACTGGA
R: TACTCCATCAGGGTATCCTC
F: GCTTACACACAGAAATGGCC
Xue et al., 2016
R: AGCACCTTCCACGTTGCTGA
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Casp3
Casp9

Bax
Bid
Chop
Nrf2

Nqo1

Hox1
xCt

hnRNP
AB

NM_00
9810.3
NM_00
1277932
.1
NM_00
7527.3
NM_00
7544.4
NM_13
4248.2
NM_00
1011167
8.2
NM_00
8706.5

226

NM_02
2994.3
NM_01
1990.2

270

152

156
96
260
94

424

182

F: CCTCAGAGAGACATTCATGG
R: GCAGTAGTCGCCTCTGAAGA
F: AGTTCCCGGGTGCTGTCTAT
R: GCCATGGTCTTTCTGCTCAC
F: AGTGATGGACGGGTCCGGGG
R: GGCGGCTGCTCCAAGGTCAG
F: TCTGAGGTCAGCAACGGTTC
R: CTCTTGGCGAGTACAGCCAG
F: ATGCCCATCTTCTGCTTGTCA
R: CCTTGTAGTTGTGGGTCTTGT
F: GCAGAGACATTCCCGTTTGT
R: CCTGAGGAGGAGCAGTGAAG
F:
TCACAGGGGAGCCGAAGGACT
R: GGGGTGTGGCCAATGCTGTA
F: GCTCTATCGTGCTCGCATGA
R: AATTCCCACTGCCACGGTC
F: CCTGGCATTTGGACGCTACAT
R:
TCAGAATTGCTGTGAGCTTGCA
F: TTTGGCGAGTTTGGGGAGATT
R:GCCATACTGCTGCTGCTGATA
GAC
F: CGGGATCGGACCCAGGAGTTC
R: CAAAGAGGGACTTGCGCTTTG

NM_00 204
1048061
.1
Stx5a
NM_00 205
1167799
.1
* F = Forward primer, R = reverse primer.
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Jia et al., 2016
Chen et al., 2012
Shi et al., 2018

Wang et al.,
2017

Hosoya et al.,
2002

Tanaka et al.,
2017

Table 2: Statistical analysis of the mRNA expression and other variables.
mRNA
expression or
other
variables
Bcl2
Bid
Csn1s1
Csn2
CytS
Gadd153
Hif1a
Il1B
Il6
Lalba
Nqo1
Nrf2
Slc2a1
Tnfa
xCt
1
CC3 protein
Csn2 protein
Csn1s1
protein
Hypoxyprobe
staining
density
TAC2
H2O23

Treatment

Time

Time x
Treatment

12 h
Treatment

24 h
Treatment

0.363

0.551
0.090

0.530

0.823
0.410
0.982
0.022
0.246
0.559
0.138
0.004
<0.001
0.016
0.05
0.244
0.674
0.046
0.117
0.021
0.0001
0.992

0.311
0.499
0.013
0.004
0.704
0.006
0.650
0.002
0.008
0.013
0.240
0.153
0.238
0.011
0.076
0.698
0.006
<0.001

<0.001

<0.001

0.067
<0.001

0.061
<0.001

0.293
0.058
0.001
0.539
0.040

<0.001
0.017
0.571
0.834
0.269
0.003

0.211
0.324
0.314

0.881
0.061
0.607
0.270
0.012
0.165
0.688
0.412

0.233
0.711
0.616
<0.001
0.506

0.440
0.035
0.075
0.607
0.598

0.026
0.031
<0.001

0.001
0.075
0.088

0.855
0.074

0.007

0.003

0.007

0.315
<0.001

<0.001
0.011
0.935

0.013
0.164
0.334
0.054

0.561

<0.001
0.411
0.049

<0.001
0.858
<0.001

1

CC3 = cleaved caspase 3, 2 TAC = total antioxidative capacity, 3 Hydrogen peroxide
level,
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Table 3: Statistical analysis of the expression of markers that presented side
difference.
mRNA
expression or
other variable

Treatment

Side

Time

Bax
Casp3
Casp9
Hox1
Lalba Protein

0.004

0.003
0.006
0.005
0.002
0.009

0.507
0.083
0.080
0.267
0.820

0.521
0.592
0.488
0.005
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Time*
12 h
24 h
Treatment Treatment Treatment
0.026
0.123
0.405
0.035
0.518

<0.001
0.127
0.835
0.239
0.001

0.467
0.495
0.319
0.056
0.003

Figure Legend
Figure 1: Liposaccharide (LPS) Challenge Incurs Mammary Gland Inflammation. The
left and right sides of fourth mammary gland are alternatively injected with LPS or PBS
through teats at day 3 of lactation. The injected glands are individually collected after 12
or 24 h of injection (n=8). A-D: Hematoxylin and Eosin staining of formalin-fixed,
paraffin embedded mammary tissue sections of 12 h (A: PBS; B: LPS) and 24 h (C: PBS;
D: LPS). E-H: mRNA expression of cytokines Interleukin-1β (E: Il1B), Interleukin-6 (F:
Il6), and Tumor Necrosis Factor-α (G: Tnfa) by real-time quantitative PCR. Relative gene
expression of cytokines is calculated by 2^^(-ddCt) method and normalized by the
mRNA levels of the internal control housekeeping genes ActinB, GAPDH, HRPT, Stx5a
and hnRNPAB. Error bars represent standard error, and different letters above each bar
indicate significant differences. Significance is declared when (P < 0.05).
Figure 2. Liposaccharide (LPS) Treatment Induced Apoptosis in the Mammary Gland.
Mammary tissues treated with PBS or LPS for either 12 or 24 h (n=8) are collected and
analyzed by real-time PCR for mRNA expression (A, D-I) or western blot for protein
levels (B: representative blots with animal numbers, C: quantitative representation).
Caspase 3 (A: Casp3), cleaved caspase 3 (B: CC3), Caspase 9 (D: Casp9), Bcl-2associated protein X (E: Bax), endoplasmic reticulum stress marker C/EBP Homologous
Protein (F: CHOP; GADD153), (G) B-Cell Lymphoma 2 (G: Bcl2), (H) Cytochrome-C
(I: CytS) and BH3-interacting domain (I: Bid) Relative mRNA expression is calculated
by 2^^(-ddCt) method and normalized by expression levels of housekeeping genes
ActinB, GAPDH, HRPT, Stx5a and hnRNPAB. Protein expression of CC3 was
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normalized by GAPDH. Error bars represent standard error, and different letters above
each bar indicate significant differences. Significance is declared when (P < 0.05).
Figure 3. Liposaccharide (LPS) Increases Oxidative Stress and Activates the
Antioxidative Response in the Mammary Gland. Mammary tissues treated with PBS or
LPS for either 12 or 24 h (n=8) are collected and analyzed for the concentration of
hydrogen peroxide (A), total antioxidant capacity relative to antioxidant standard Trolox
(B) and mRNA expression of Nuclear erythroid-related factor 2 (C: Nrf2), NAD(P)H
quinone oxidase 1 (D: Nqo1), cysteine transporter xCT, (E), and Heme oxygenase 1 (F:
Hox1). Gene expression is calculated by 2^^(-ddCt) method and normalized by the levels
of housekeeping genes ActinB, GAPDH, HRPT, Stx5a and hnRNPAB. Error bars
represent standard error, and different letters above each bar indicate significant
differences. Significance is declared when (P < 0.05).
Figure 4. Effect on Liposaccharide (LPS) Treatment on Hypoxic Condition in the
Mammary Gland. Mice are injected intraperitoneally with pimonidazole HCl, and
mammary tissues are treated with PBS or LPS for 12 or 24 h (n=8). A-C: Representative
immunostaining of hyproxyprobe in A: the LPS-treated gland and B: PBS-treated gland
at 12 h. C: Negative control staining is performed by the omission of the first antibody
against hypoxyprobe. D: Quantitative representation of relative hypoxic condition in
LPS- and PBS-infused glands. E & F: mRNA expression of hypoxia-inducible factor 1
(Hif1a, E) and glucose transporter 1 (Slc2a1, F) by real-time PCR. Relative gene
expression is calculated by 2^^(-ddCt) method and normalized by the expression levels of
housekeeping genes ActinB, GAPDH, HRPT, Stx5a and hnRNPAB. Error bars represent
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standard error, and different letters above each bar indicate significant differences.
Significance is declared when (P < 0.05).
Figure 5. Liposaccharide (LPS) Challenge Reduces Milk Protein Expression in the
mammary gland. Mammary tissues treated with PBS or LPS for 12 or 24 h (n=8) are
collected and analyzed by real-time PCR for mRNA expression (A-C) and western blot
for protein levels (D-F: quantitative presentation, G: representative images with animal
numbers) of β-casein (A&D: Csn2), α-lactalbumin (B&E: Lalba), and α-S1-casein (C&F:
Csn1s1). Relative mRNA expression is calculated by 2^^(-ddCt) method and normalized
by the expression of housekeeping genes ActinB, GAPDH, HRPT, Stx5a and hnRNPAB.
In D-F, relative protein levels of milk proteins are normalized by the levels of GAPDH
(D). Error bars represent standard error, and different letters above each bar indicate
significant differences. Significance is declared when (P < 0.05).
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Chapter 3: General Discussion
Our study presents evidence that LPS challenge of the mammary gland induces
programmed cell death in the early stage of mastitis. LPS challenge increases Bax gene
expression and caspase 3 cleavage at 12 h in addition to raising oxidative stress and
lowering the antioxidative capacity of the mammary gland. Other LPS IMI studies have
also demonstrated similar trends of these individual markers, thus corroborating our
findings (Habelhah et al., 2016; Zowalaty et al., 2018; Jeong et al., 2017). However,
more information is needed to determine the cellular stimulator of LPS-induced
apoptosis. Future research is required to compare the ER-stress in relation to
mitochondrial dysfunction in LPS-stimulated mastitis. The ER crosstalks with the
mitochondria of a cell through soluble factors, such as calcium, and protein:protein
interactions between the organelles to coordinate anti-apoptotic or pro-apoptotic
signaling among other functions (Malthotra et al., 2011; van Vliet et al., 2018; Senft et
al., 2015). In addition, the use of Bax inhibitors in cancer therapies is an emerging field
(Barclay et al., 2015; Li et al., 2017; Niu et al., 2017), and these compounds could be
utilized in future research for therapeutics supporting mastitis recovery.
Our data show that while Nrf2-ARE genes xCt and Nqo1 are upregulated, gene
expression of Nrf2 is not induced by LPS treatment. The possible reason for this
discrepancy is that Nrf2 is primarily regulated at its translocation to the nucleus following
dissociation from KEAP1. This research provides preliminary data to investigate the
effects of antioxidative compounds or agonists that improve Nrf2-ARE signaling, such as
polyphenolic compounds and tBHQ (Wang et al., 2019; Hu et al., 2018; Su et al., 2018;
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Jin et al., 2016; Song et al., 2015) on milk protein synthesis and changes in cell death and
stress during mastitis.
In this study, we observe a reduction in mRNA and protein expression of Csn2
and Lalba by LPS challenge at both 12 and 24 h, but Csn1s1 mRNA is increased at 24 h
and its protein level is inhibited only at 24 h. These differential effects remain unclear,
but this is evidence that alpha-S1 casein is a protein of interest in immune function.
Vordenbäumen et al. (2016) have shown that alpha-S1 casein stimulates human
monocyte differentiation to macrophages, but the impact of alpha-S1 casein expression in
vivo remains unknown. Outside of this function, the control mechanisms of the
differential expression of milk proteins remain unknown at the gene and protein levels.
The protein abundance of alpha-S1 casein, unlike its mRNA, significantly decreases in
the mammary gland at 24 h after LPS treatment, indicating an inhibition at the posttranscriptional levels.
One way to study the potential mechanism of the differential regulation of milk
protein gene expression by LPS would be through chromatin immunoprecipitation assays
to compare if there are unique interactions between NF-kB and the gene promotor of
Csn1s1 that are not occurring in neither the Csn2 nor Lalba genes. In addition, future
research of the impact mastitis has on Csn2 and Lalba should elucidate how the gene and
protein expression of Csn2 and Lalba are repressed by the signaling of inflammation,
oxidative stress, and programmed cell death pathways. Particularly, the interaction of
pro-inflammatory NF-kB, antioxidative factors FOXO and Nrf2, cell survival factor AP1, and p53 apoptosis transcription factor with the Csn2 and Lalba promoters must be
thoroughly examined through real time in mastitis (Zhang et al., 2018; Gào et al., 2017;
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Qin et al., 2016; Kunnumakkara et al., 2018). The Csn2 gene promoter has already been
thoroughly examined for potential binding sites for most of these transcription factors,
but they have not been investigated in mastitis (Malewski et al., 1995).
Another interesting study would be to determine if alpha-S1 casein is processed
post-translationally in a manner that is not seen in other milk proteins like Csn2 and
Lalba. Saenger et al. (2019) found that unphosphorylated, but not phosphorylated
Csn1s1, stimulated the inflammatory response. Lactation stage, parity, and genetic
variation of cattle all contribute to different levels of milk protein phosphorylation
throughout the lactation cycle of an individual animal, thus differential phosphorylation
may result from mastitis too, which requires future research to confirm (Fang et al.,
2017). There is also evidence of two different pathways of casein phosphorylation for
low and high phosphorylated residues, thus the impact of mastitis on these pathways
warrants investigation (Fang et al., 2016). Casein kinase 1 has been shown to be a
negative regulator of FOXO, which promotes apoptosis due to ROS (Farhan et al., 2017).
Casein kinase 2 has also shown differential activity as it is upregulated in hypoxic
environments in a HIF-1α induced manner (Mottet et al., 2005).
Phosphorylation and post-translational proteolysis are two of the main controls for
post-transcriptional regulation of milk protein expression. Proteolytic digestion of casein
proteins can enhance their bioactivity and has also been shown to have immune impacts.
α-S1 casein protein digests presented anti-hypertensive properties while β-casein peptides
produce agonists of µ-opioid receptors which activate the immune response (Saito et al.,
2003). The expression of such casein derivatives under inflammatory conditions is
unclear, but pH, which increases in mastitis, has been shown to alter milk protein
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structures and can dictate the activities of the proteases which act on the milk proteins
(Gan et al., 2019). Another factor to consider is that bacteria secrete their own proteases,
thus cleavage can vary from one infectious strain to another and may be a mechanism to
evade the immune system (Gan et al., 2019).
A way to observe Csn1s1 function in the immune system would be to compare the
effects of mastitis on normal mice and Csn1s1-/- knockout mice. In such study, the
effects of LPS intramammary infusion would be examined in relation to the inflammatory
signaling and immune cell recruitment to see if less immune cells of different types are
recruited in mammary glands of Csn1s1-/- knockout mice. Csn2-/- knockouts have been
previously documented and showed that casein micelles were smaller in Csn2-/knockout mice, and while the milk was not as nutritious as the wild-type, there was no
difference in disease susceptibility (Kumar et al., 1994).
Our study demonstrates that the IMI of LPS enhances the oxygen tension of the
mammary gland at 12 and 24 h as LPS glands present less localized hypoxia than in PBS
treated glands. This was opposite to our original thoughts. In infections, increased HIF-1α
is commonly observed in addition to higher glycolytic enzyme and VEGF gene
expression (Ge et al., 2019). Thus, we originally hypothesized that this response is due to
decreased oxygen tension resulting from the massive recruitment of immune cells. Our
observation in this study contrasts with this hypothesis, which may be due to increasing
blood supply during inflammation after 24 h or decreasing oxygen utilization due to a
metabolic shift to an anaerobic metabolism.
While the oxygen tension is increased by LPS challenge in our study, the mRNA
expression of HIF-1α and GLUT1, two hypoxia markers, is not increased. This can be
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explained by 1) LPS does not induce hypoxia in the mammary gland and 2) HIF-1α is
mainly regulated at its degradation and translocation. The treatment of smooth muscle
cells with TNF-α also presented a failure to induce HIF-1α transcriptional activity in the
inflammation-dependent nonhypoxic pathway (Richard et al., 2000; Tsapournioti et al.,
2013). HIF-1α has been shown to activate AMPK, which inhibits biosynthetic pathways
like the mTOR pathway (Bohensky et al., 2010), thus HIF-1α potentially may not
participate in the repression of milk protein synthesis in LPS-induced mastitis. While it
may not support milk synthesis, the promotion of hypoxia signaling in the face of
inflammation can support the outcome of damage and cell death incurred by mastitis via
metabolic reprograming and angiogenesis. Many studies have demonstrated that
increasing HIF-1α expression increases the survival of cells and improves the prognosis
of inflammatory conditions by using indirect agonists, such as PHD inhibitor
GSK1278863 (Wigerup et al., 2016; Holdstock et al., 2016; Maxwell et al., 2016). HIF1α activity can also be promoted by impairing its interaction with the repressive vHL
(Xue et al., 2016). Investigation of effects of HIF-1α agonism or antagonism on the
outcome of mastitis may be worthwhile to demonstrate the therapeutic potential of HIF1α in future mastitis treatment research.
In this study, although we use a unilateral design to reduce individual differences
between the treatment and control, large individual variances are still seen between
animals in the expression of many genes. The expression of genes involved in oxidative
stress and apoptosis, such as xCt and Casp9 and Chop, present large numerical
differences between LPS treatment and control, but a statistical difference is not able to
be declared for these observations due to large standard errors. The large expression
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variances between animals could have been due to asymmetric mammary development
between individuals, differences in litter size, and milking frequency of the sampled
gland (Robichaux et al., 2015; Wasson, 2017; Knight & Peaker, 1982; Murney et al.,
2014; Alex et al., 2015), and these reasons support our unilateral model to increase the
power of the treatment.
However, one of the weaknesses of our unilateral design is the potential presence
of systemic effect of LPS. LPS injected into one gland may eventually enter the
bloodstream and reach the opposite mammary gland. The systemic effects of LPS are
widely documented (De Matteis et al., 2017; Guo et al., 2019; Kan et al., 2019;
Pawlowski et al., 2016), thus, we cannot rule out the possibility of the presence of LPS
effects on the PBS-injected gland in this study. Nevertheless, our study clearly shows the
differences between LPS- and PBS-injected glands, indicating that any LPS effects on the
PBS-injected gland should be minimal compared with the LPS-injected gland.
Another weakness of our study is that no milk was collected from the animals.
While it is possible to milk mice and receive a substantial amount of milk for analyses,
we decided not to collect milk from the animals in this study because one of our major
objectives of this study was to examine if mastitis causes localized hypoxia in the
mammary gland. The palpation process in milking and milk-letdown could have
interfered with the oxygen tension of the mammary gland before tissue harvest and could
also cause damage to the mammary gland to jeopardize the study (Keen et al., 1980).
A third drawback of this study is that our observations were done in tissue
samples which contained many types of cells. Unlike immunohistochemistry, RT-qPCR
and western blot analysis data may not be accurately representative of MEC specific gene
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and protein expression, respectively. For example, infiltrating immune cells entering the
mammary gland express pro-inflammatory cytokines and HIF-1α at greater amounts than
most cells and could dilute the total expression of genes and proteins expressed by MECs
(Zinkernagel et al., 2007). Thus, future studies should use laser capture microdissection
in tissues to target specific cell populations or study specific cell effects in vitro and in
vivo. The methods of cell isolation are just entering the field of dairy science and present
a great opportunity to understand the cellular and molecular complexity that culminates
in mastitis (Sridhara et al., 2017; Bach et al., 2017; Pal et al., 2017; Giraddi et al., 2018).
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